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ABSTRACT 
 
Airaksinen, S.T.T., 2005. Role of excipients in moisture sorption and physical stability of 
solid pharmaceutical formulations. 
 
Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki, 20/2005, 
pp. 57, ISBN 952-10-2733-9 (print) ISBN 952-10-2734-7 (pdf) ISSN 1795-7079  
 
The interaction of moisture with pharmaceutical solids is crucial to an understanding of 
water-based processes, e.g. manufacturing processes or prediction of solid dosage form 
stability and shelf life. Sorbed moisture of either the active pharmaceutical ingredient (API) 
or excipients in the pharmaceutical formulation can result in unexpected processing-
induced phase transformations (PITs). Phase transformations in formulations can lead to 
instability in physicochemical, biopharmaceutical, and processing properties of products. 
Thus correct selection of excipients helps to control PIT and can improve the storage 
stability of the final formulations. The aim of this thesis was to study the effect of water in 
different excipients and explain the water-excipient interactions with special regard to the 
formulation and manufacturing of solid forms.  
 This study examines the moisture sorption properties of several excipients with 
different degree of crystallinity after storage at various levels of humidity. This facilitates 
comparison of excipients regarding to preformulation stage, and thus helps predict the 
solid-state stability and interactions of the final formulations. The degree of crystallinity of 
excipients had a significant effect on the stability of formulation. The crystallinity of 
excipients was correlated with the ability of the excipients to inhibit hydrate formation of 
two model APIs. Only amorphous, hygroscopic excipient in the formulation was able to 
inhibit hydrate formation of API at relatively high water contents during wet granulation. 
Slightly hygroscopic partially crystalline excipient hindered hydrate formation of API at 
low water contents. Non-hygroscopic crystalline excipient could even enhance the hydrate 
formation of API. In general, the more amorphous the excipient, the more water was 
absorbed into its structure and the slower was the rate of API hydrate formation. With low 
water contents, a spectroscopic approach enabled phase transformations in the formulation 
to be identified even though there were excipients in the formulation. Finally, the effect of 
temperature changes on the dehydration behaviour of formulations and solid-state 
properties of excipients was evaluated. Process temperature and excipients used in the 
formulation had a significant influence on phase transitions. 
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1. INTRODUCTION 
The pharmacopeial requirements for a pharmaceutical dosage form may be summarized in 
terms of safety, purity, efficacy and stability. Final pharmaceutical dosage form generally 
consists of an active pharmaceutical ingredient (API) combined with a varying number of 
excipients. Because many new drug candidates exhibit poor solubility and stability, the 
function of excipients is to define a formulation that is physically and chemically stable, 
manufacturable, and bioavailable (Joshi 2004). The excipients may function as a stability 
enhancer and therefore they should protect, support, or enhance stability or bioavailability 
of formulation (Crowley 1999). The excipients are also known as promoters of the 
degradation of drug substances: functional groups or residues in excipients can have the 
propensity to interact with unstable API. Physical changes in the formulation can lead to 
altered dissolution or other delivery properties of the final dosage form. Physical stability is 
used to refer to the stability of an API with respect to physical transformations, e.g. to 
another polymorph or pseudopolymorph. In addition to physical stability, phase 
transformations in formulations can influence other pharmaceutical properties, such as 
flowability and compressibility of starting material, and biopharmaceutical properties, such 
as dissolution rate and bioavailability of the final dosage form. Thus, it is important to 
determine whether phase transformations occur, and if so, what factors influence them.  
 The physical and chemical properties of pharmaceutical solids are critically dependent 
on the presence of water: e.g. flow, compaction, dissolution, stability, storage, processing 
into formulations and final product packing (Kontny and Zografi 1995). Physical form 
changes can occur at various stages of the formulation process, e.g. during wet granulation, 
which is a widely used process of agglomeration in the pharmaceutical industry. 
Pharmaceutical materials may come into contact with water during manufacturing 
processes and some moisture could remain as the residual water from processing in solid 
dosage forms. Moreover, they may be exposed to water during storage at high relative 
humidities (RHs) or in a dosage form consisting of materials that contain water and are 
capable of transferring it to other ingredients (Khankari and Grant 1995). To understand 
and to predict the effects of water on the properties of solid materials, it is necessary to 
understand the state of water in solids, and the mechanisms of water sorption in different 
materials (Kontny and Zografi 1995).  
 Because most of pharmaceutical products are solids like tablets and capsules, the 
influences of formulation design on the optimal solid dosage forms should be specified. 
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The object of pharmaceutical development is to design a quality of product and the 
manufacturing process to deliver the final product in a reproducible manner (ICH 2004). It 
is important to recognize that quality cannot be tested only in final products, but quality 
should be built in by design and controlled during the manufacturing process. Many factors 
related to moisture and physical stability may induce unexpected phase transformations. 
Therefore the solid-state properties of the API as well as the excipients must be understood 
in order to ensure consistent dosage form. 
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2. THEORY AND REVIEW OF THE LITERATURE 
2.1 Water-solid interactions 
2.1.1 Water and intermolecular forces 
The water molecule consists of two hydrogen atoms, which are covalently bound to an oxygen 
central atom. Water molecules attract each other through the special type of dipole-dipole 
interaction known as hydrogen bonding, which includes the polarity of water molecules. The 
hydrogen bond is a specific type of electrostatic attraction between molecules. The forces 
holding molecules together are generally called intermolecular forces and these electrostatic 
forces play important roles in determining the physical properties of a material. The hydrogen 
bonds that form between water molecules account for some of the unique properties of water. 
The attraction created by hydrogen bonds keeps water as a liquid over a wider range of 
temperature than is found for any other molecules of its size. Thus, the state of water molecules 
under a given set of conditions, and hence their many physico-chemical properties, depend on 
their hydrogen-bonding ability (Zografi 1988). Also e.g. crystalline snowflake structure is due to 
hydrogen bonding. 
 When molecules interact with each other, the forces can be attractive or repulsive 
depending on whether like or unlike charges are closer together. The two types of attractive 
forces are called cohesive (like molecules attract each other) and adhesive forces (different 
molecules attract each other). The intermolecular forces are weaker than the intramolecular 
forces (the chemical bonds within an individual molecule). Weak intermolecular bonds in 
liquids and solids are often called van der Waals forces. The cohesive forces that operate during 
wet granulation process are mainly due to the liquid bridges between the solid particles, even 
though intermolecular attractive forces, van der Waals forces, and electrostatic forces also play 
an initial role (Augsburger and Vuppala 1997). Both hydrogen bond and hydrophobic effect are 
relevant to the interactions of water (Israelachvili 2003). Forces of attraction between nonpolar 
atoms and molecules in water are called hydrophobic interactions, which are due to van der 
Waals types of intermolecular attractive forces. However, the interaction of water with itself is 
much more attractive. 
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2.1.2 Interaction mechanisms 
Water can interact only at the surface of solids, this is known as adsorption, and water can 
penetrate the bulk solid structure, this is known as absorption (USP 1995). The amount of water 
sorbed is a function of the affinity between the surface and water molecules, temperature, RH 
and, in case of adsorption, also the amount of exposed surface area. Sorption is used as a general 
term to cover both adsorption and absorption but also desorption or resorption. Adsorption 
occurs whenever a solid surface is exposed to a gas or liquid, and gas adsorption has become 
one of most widely used procedures for determining the surface area and pore size distribution 
of powders and porous materials (Rouquerol et al. 1999). Two kinds of forces are involved: a 
distinction could be made between physical adsorption (physisorption) in which the van der 
Waals interactions are involved, and chemical adsorption (chemisorption) where the adsorbed 
molecules are attached by chemical bonding and hence chemisorption is irreversible. 
Physisorption is reversible and a physically adsorbed gas may be desorbed from a solid by 
increasing the temperature and reducing the pressure. Chemisorbed molecules are linked to 
reactive parts of the surface and the adsorption is necessarily confined to a monolayer, whereas 
physisorption generally occurs as a multilayer at high relative pressures (Rouquerol et al. 1999). 
This study is focussed on physisorption. 
 The gas or vapour taken up on surface is called the adsorbate, when the solid that takes up 
the gas or vapour is usually called the adsorbent or more general sorbent. The tendency for 
adsorption onto a solid surface is strongly dependent on the vapour pressure, the temperature, 
and the magnitude of the interfacial binding energy (Zografi 1988). The interactions between 
moisture and solids have been described in different ways. The adsorption process occurs with 
the water forming hydrogen bonds with the hydrophilic sites on the surface of the solid (Brittain 
1995). Water molecules first adsorb onto the surfaces of dry material to form a monomolecular 
layer, which is subjected to both surface binding and diffusional forces (Fig. 1). Diffusional 
forces exceed the binding forces as more water molecules adhere to the surfaces and moisture is 
transferred into the material (York 1981). So, moisture is adsorbed as mono- or multilayers or 
may be present as normally condensed moisture. Multilayer water adsorption consists of water 
uptake into pores and capillary spaces, dissolution of solutes, and finally the mechanical 
detention of water (Barbosa-Cánovas and Vega-Mercado 1996). Unbound, free water is loosely 
adsorbed on the surface of the material and behaves as pure water. Bound water is directly or 
tightly associated with a material and is not readily available for chemical interaction. 
Additionally, some water is moderately or loosely bound between tightly bound and free water. 
Thus, the amount of free water rather than the amount of total water is critical to the chemical 
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and physical stability of a moisture sensitive drug substance. The amount of water adsorbed is a 
function of the affinity between the surface and water molecules, temperature, water vapour 
concentration (i.e. pressure, be it expressed as partial pressure, relative pressure, RH) and, of 
course, the absolute amount of exposed surface area. In addition to those molecules that adsorb 
directly onto the surface of the solid, additional molecules may condense in pores depending on 
the pore size. 
 
 
Figure 1. Three different ways in which water can 
be located within a solid (modified from York 
1981). (A) A monomolecular layer of water bound 
to the surface (monolayer adsorbed water), (B) 
moisture within the material (absorbed water), (C) 
multimolecular layers of water (condensed water). 
 
Water activity (aw), or equilibrium relative humidity (ERH) are measures of the free water in a 
pharmaceutical dosage form (Bell and Labuza 2000). It is defined as the ratio of the water 
vapour pressure of the substance (p) to the vapour pressure of pure water (p0) at the same 
temperature; 
 
0p
pa w =  (Eq. 1) 
Equilibrium relative humidity is water activity expressed as a percentage; 
  (Eq. 2) 100×= waERH
At equilibrium, the water activity of a material is equal to the relative humidity (RH) of the 
atmosphere in which it is stored. Moisture uptake rate depends on the RH of the environment 
and the time (Kontny and Zografi 1995). The water activity reflects a combination of water-
solute and water-surface interactions as well capillary forces and it usually increases with 
temperature and pressure increases. Water activity influences the chemical stability, microbial 
stability, flow properties, compaction, hardness, and dissolution rate of dosage forms of 
pharmaceuticals.  
 Micropores and mesopores are claimed to be important in the context of moisture sorption 
(Rouquerol et al. 1999). The pore size is generally specified as the pore width, i.e. the diameter 
of cylindrical pore or distance between the two opposite walls (Rouquerol et al. 1999). Limits 
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for the size of the different categories of pores have been proposed by the International Union of 
Pure and Applied Chemistry (IUPAC, after Sing et al. 1985): micropores (pores of internal 
width less than 2 nm), mesopores (pores of internal width between 2 and 50 nm) and 
macropores (pores of internal width greater than 50 nm).  
 In capillary condensation the residual pore space which remains after multilayer 
adsorption has occurred is filled with condensate separated from the gas phase by menisci 
(=curvature of the liquid surface in the capillary) (IUPAC, after Sing et al. 1985). Water is 
adsorbed into the surface of the pore wall at first and then water is condensed and fills the core 
of the pore (Aharoni 1997). Capillary condensation is associated with a decrease in the surface 
energy at the interface between the pore walls and the sorbate. Capillary condensation is 
responsible for mesopore and macropore filling (Rouquerol et al. 1999). According to the 
classical interpretation, the phenomenon is explained by application of the Kelvin equation:  
 ϕγ cos2ln
0 rRT
V
p
p L−=  (Eq. 3) 
where p is the equilibrium vapour pressure of a liquid in a pore of radius r, p0 the equilibrium 
pressure of the same liquid on the plane surface, γ is the surface tension of the liquid, VL is the 
molar volume of the liquid, ϕ is the contact angle with which the liquid meets the pore wall, R is 
the gas constant and T is the absolute temperature (Rouquerol et al. 1999, Beurroies et al. 2004).  
 
2.1.3 Effect of nature of a material  
Hygroscopicity 
Hygroscopicity is the ability of a material to interact with moisture from the surrounding 
atmosphere. In general materials unaffected by water vapour are termed non-hygroscopic while 
those in dynamic equilibrium with water in the atmosphere are hygroscopic. Callahan et al. 
(1982) have classified the degree of hygroscopicity into four classes:  
1. non-hygroscopic solids: no increase in water content at < 90% RHs,  
and increase after storage for one week above 90% RH is less than 20%. 
2. slightly hygroscopic solids: no moisture increase at < 80% RHs  
and increase after one week storage less than 40% at > 80% RH. 
3. moderately hygroscopic solids: moisture increase ≤ 5% after storage at below 60% RH, 
and after storage for one week at > 80% RH is less than 50% moisture. 
4. very hygroscopic solids: moisture content increase may occur at 40-50% RH  
and increase may exceed 30% after storage for one week > 90% RH.  
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Normally adsorbed water does not affect the solid to any huge extent before it condenses at the 
particle surface (Van Campen et al. 1983). At high humidity solid water-soluble particles at the 
surfaces begin to dissolve in adsorbed water vapour and form a saturated solution (Van Campen 
et al. 1983, Kontny and Zografi 1995). This will eventually lead to the deliquescence of the 
solid. Because a solution is being created, the moisture content rises significantly (Kontny and 
Zografi 1995). The RH at which deliquescence first occurs is characteristic of the individual 
solid and its storage temperature, and it is commonly termed the critical relative humidity (RH0), 
which is the RH over the saturated solution of the substance (Kontny at al. 1987, Kontny and 
Zografi 1995). The phenomenon of deliquescence is important in pharmaceutical systems 
because the exposure of solids to humidities above RH0 results in the formation of a liquid phase 
where chemical reactions may be accelerated or physical changes catalysed (Hancock and 
Shamblin 1998). Deliquescence and capillary condensation are capable of dissolving water-
soluble components (Ahlneck and Zografi 1990). Condensed water, which is produced during 
deliquescence, continues to dissolve the solid as long as a sufficiently high RH is maintained: 
actual dissolution of water-soluble 
crystalline substances does not 
occur below RH0. Typically poor 
water-soluble compounds have 
RH0 values around 90% at 25 °C 
and when solubility increases, RH0 
decreases (Kontny and Zografi 
1995). The steps in the uptake of 
water vapour by water-soluble 
solids are presented in Fig. 2.  
Figure 2. Water vapour adsorption and deliquescence of a water-
soluble solid particle (modified from van Campen et al. 1983). 
 
Crystalline solids 
Water can interact with crystalline solids in four different ways: 1) adsorption on the surface of 
the particles, 2) incorporation into microporous regions by capillary condensation, 3) formation 
of crystal hydrate, and 4) deliquescence (Ahlneck and Zografi 1990). The crystal structure, 
water-solubility, porous structure, and the ability to form crystal hydrates determine the 
mechanism of water sorption into the solid (Dawoodbhai and Rhodes 1989). Because of the 
close packing and high degree of order of the crystal lattice, most crystalline solids will not 
absorb water into their structures (USP 1995). The adsorption of water onto nonhydrating 
crystalline solids depends on the polarity of the surfaces and is proportional to surface area 
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(Kontny and Zografi 1995). If the specific surface area is large, e.g. very small or porous 
particles, the adsorption is particularly critical in affecting the properties of solids (USP 1995).  
 Crystalline excipients are typically non-hygroscopic. At low RH water is adsorbed onto 
the surface of crystalline material (Fig. 2). As RH increases, the water molecules become 
attached at the solid-vapour interface by weak interaction forces, e.g. van der Waals forces 
(Hancock and Shamblin 1998). Water primarily interacts with the polar groups on the crystalline 
surface (Bell and Labuza 2000). This is a surface effect and thus surface area, particle size and 
size distribution are important for the ability to adsorb moisture as a function of RH. As the RH 
is increased, some tendency for multilayer sorption is expected (Kontny and Zografi 1995).  
 At a characteristic RH a complete monolayer of water molecules will be formed on the 
surface of the crystalline solid particles (Hancock and Shamblin 1998). Since most crystalline 
solids have low specific surface areas (< 1 m2/g), they will adsorb much less than 0.1% (w/w) 
water vapour even at very high humidities and low temperatures. The adsorption of water 
molecules at the surface of crystalline particles may alter their bulk powder properties, like flow 
and compressibility, which depend upon interparticle attractions and surface properties. It has 
been suggested that enhanced chemical and physical reactivity at the surface of crystals in the 
presence of water vapour may be due to plasticization of small disordered, amorphous, regions 
(Kontny et al. 1987).  
 
Amorphous solids 
Amorphous solids consist of disordered arrangements of molecules and do not own a 
distinguishable crystal lattice. Amorphous part of solids can absorb significant amounts of 
moisture within the material. Water absorbed into the amorphous regions can act as a plasticizer 
and increase molecular mobility due to the breakage of hydrogen bonds between molecules. 
Water vapour is absorbed into structure of amorphous solids and not simply adsorbed on the 
surface, thus the amount of water uptake is not directly related to the specific surface area of the 
solid (Zografi et al. 1984, Zografi 1988). The bulk properties of the solid can be significantly 
altered, when water is absorbed by amorphous solids (USP 1995). The amount of moisture 
sorbed by amorphous solids is typically much greater than that sorbed by crystalline solids 
below their critical RH0 (Kontny and Zografi 1995). The chemical and physical properties of 
sorbent (e.g. hydrophilicity or glass transition temperature), the temperature and RH, and the 
strength and nature of any interactions between the water and the solid molecules control 
moisture absorption by amorphous materials (Hancock and Dalton 1999).  
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 Amorphous solids, depending on the water content and temperature, can exist in two 
distinct states, the glassy state and the rubbery state. The glass transition occurs over a 
temperature range, which is characteristic for each amorphous material (Roos and Jouppila 
2003). Onset or midpoint temperature of glass transition is usually referred to the glass 
transition temperature (Tg). Amorphous material can absorb a large quantity of water while the 
free volume increases; water acts as a plasticizer and hence reduces Tg (Zografi 1988). 
Significantly lowering Tg below the storage temperature could cause various changes, e.g. 
crystallization (Roos and Karel 1991, Burnett et al. 2004). Thus Tg of amorphous material 
determines its stability (Roos 1993). It is important for storage and processing of amorphous 
materials to determinate the critical temperature and humidity conditions, where the glass 
transition will occur (Burnett et al. 2004). Critical values for water content and storage relative 
humidity at certain temperature have been also defined as values which reduce Tg of material to 
that certain temperature (Roos 1993). 
 
2.1.4 Classification of sorption isotherms 
Information on the sorption mechanism of water on powder surfaces can often be obtained from 
the shape of the vapour sorption isotherm, because it is dependent on the interaction between the 
vapour molecules and the solid material (Roos 1995). The physisorption isotherms may be 
classified into six major types (I-VI) according to the IUPAC classification (after Sing et al. 
1985) and shown in Figure 3. Types V and VI isotherms are not commonly observed (Sing et al. 
1985, Rouquerol et al. 1999).  
Type I is the Langmuir type, roughly characterized 
by a monotonic approach to a limiting adsorption that 
presumably corresponds to a complete monolayer 
(Langmuir 1917). Type I isotherms, are given by 
predominantly microporous adsorbents having a 
relatively small external surface area (Sing et al 1985, 
Rouquerol et al. 1999), holding large amounts of water at 
low RH. This type isotherm is typical of anticaking 
agents (Bell and Labuza 2000). The limiting uptake may 
be governed by the accessible micropore volume rather 
than by the internal surface area (Sing et al 1985, 
Rouquerol et al. 1999). The sigmoid type II isotherms, or 
Figure 3. Classification of moisture 
sorption isotherms and their possible 
shapes (after Sing et al. 1984). 
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S-shaped, are normally associated with monolayer-multilayer sorption on the nonporous or 
macroporous surface of a powder (Figs. 3 and 4). The water sorption isotherms of biological 
materials often follow the shape of the sigmoid type II isotherm and this isotherm with a 
hysteresis is obtained with plate-like particles with non-rigid slit-shaped pores (Rouquerol et al. 
1999). The resultant curve is caused by the combination of colligative effects (physical 
properties of solution), capillary effects, and surface-water interactions (Bell and Labuza 2000). 
A distinct “knee” usually indicates a formation of a well-defined monolayer. Types II and IV 
isotherms show a significant uptake at low partial pressures followed by small adsorption at 
intermediate vapour concentration and again a high uptake at elevated partial pressures (Sing et 
al 1985, Rouquerol et al. 1999). A hysteresis loop is commonly associated with the presence of 
mesoporosity and it is a common feature of both type II and type IV isotherms. Unlike type IV 
isotherms, hysteresis of type II has no plateau at high aw. The characteristic shape of a type IV 
isotherm is a consequence of surface coverage of the mesopore walls followed by capillary 
condensation or pore filling (Sing 1998). Type III and V isotherms indicate weak adsorbent-
adsorbate interactions and they show a characteristic low uptake at low concentration and a 
strong increase in sorption at higher vapour concentration (Sing et al 1985, Rouquerol et al. 
1999). The type III isotherm appears when all the sorption occurs according to a multilayer 
mechanism throughout the pressure range. Some crystalline materials, e.g. sugars, may have a 
fairly low adsorption of water until deliquescence, at which point the sorption increases and 
follows the type III isotherm. Type VI isotherm, stepped isotherm, introduced primarily as a 
hypothetical isotherm and is associated with layer-by layer sorption on a uniform nonporous 
surface (Rouquerol et al. 1999).  
 The difference between adsorption and desorption isotherms is called hysteresis (Fig. 4), 
which is generally associated with capillary condensation in mesopore structures: capillary 
evaporation occurs at a lower relative pressure than capillary condensation (Sing et al. 1985, 
Barbosa-Cánovas and Vega-Mercado 1996, Bell and Labuza 2000, Thommes et al. 2002). 
Water can be held and trapped internally in the mesopores below the aw where the water should 
have been released (Bell and Labuza 2000). The size and shape of the hysteresis loop itself can 
also provide a useful indication of the predominant pore-filling or -emptying mechanisms (Sing 
1998). Hysteresis loops at high RH are often identified in highly porous materials and at low RH 
are often associated with swelling or some other type of interaction between the sorbate and 
sorbent in the bulk (Sing et al. 1985, Mihranyan et al. 2004). Also, the transition between a 
glassy and rubbery state or the supersaturation of material, e.g. sugars, during desorption can 
cause a hysteresis effect (Bell and Labuza 2000).  
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The common types of hysteresis loops have been classified by IUPAC (after Sing et al. 1985) in 
types H1-H4 and the characteristic features of types of loops are associated with the geometry 
and texture of the mesoporous adsorbent (Rouquerol et al. 1999, 
Thommes et al. 2002). Type H1 loops are often obtained with 
spheroidal agglomerates or particles of fairly uniform size and a 
narrow distribution of uniform pores (Gregg and Sing 1982). A 
hysteresis loop of type H2 is expected, if network- and pore 
blocking effects are present and the distribution of pore size and 
shape is not well defined (Rouquerol et al. 1999, Thommes et al. 
2002). Types H3 and H4 have been obtained with adsorbents 
having slit-shaped pores or plate-like particles (H3) (Gregg and 
Sing 1982, Rouquerol et al. 1999). In the case of type H4, the 
pore size distribution is mainly in the micropore range. Types H3 
and H4 hysteresis loops do not close until the equilibrium 
pressure is very close to, or at, the saturation pressure. Thommes 
Figure 4. A schematic representation of a sorption isotherm with a hysteresis between the 
adsorption and desorption isotherms. An isotherm can be divided into three regions: 1st region: 
water monolayer, strong hydrogen bonds. 2nd region: water multilayer (weaker hydrogen bonds to 
monolayer), capillary water. 3rd region: free or solvent water (modified from Chaplin 2005). 
Figure 5. The current IUPAC 
classification of hysteresis 
loops of sorption isotherms 
(after Sing et al. 1985). 
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et al. (2002) reported that the shape and the width of sorption hysteresis loops were dependent 
both on temperature and pore diameter. With increase in temperature most hysteresis loops 
undergo a reduction in size (Rouquerol et al. 1999).  
 Absorption of significant amounts of water into the internal structure of a solid has been 
shown to influence the properties of the solid (Kontny and Zografi 1995). This is apparent in the 
hysteresis observed between the sorption and desorption isotherms and this phenomenon 
becomes exaggerated to a greater extent for materials that consist of higher proportions of 
amorphous material.  
 
2.1.5 Moisture sorption isotherms  
The moisture sorption isotherms show the equilibrium amount of water sorbed onto a solid as a 
function of steady state vapour pressure at a constant temperature (Roos 1995, Bell and Labuza 
2000). There are many empirical equations that attempt to describe this behaviour, but the water 
sorption properties at various RHs should be experimentally determined for each material. The 
general shape of the isotherm, specific surface area of the sample, reversibility of moisture 
uptake, presence and shape of a hysteresis loop provide information on the manner of interaction 
of the solid with water (Swaminathan and Kildsig 2001). Knowledge of water sorption 
properties is important in predicting the physical state of materials at various conditions, 
because most structural transformations and phase transitions are significantly affected by water 
(Roos 1995).  
 A lot of models for moisture sorption isotherms can be found in the literature (Van den 
Berg and Bruin 1981). Langmuir (1917) developed an equation based on the theory that the 
molecules of gas are adsorbed on the active sites of the solid to form a layer one molecule thick 
(monolayer). The Brunauer-Emmett-Teller (BET) sorption model (Brunauer et al. 1938) is often 
used in modelling water sorption of pharmaceutical material and particularly to obtain the 
monolayer value (Eq. 4). Monolayer value expresses the amount of water that is sufficient to 
form a layer of water molecules of the thickness of one molecule on the adsorbing surface (Bell 
and Labuza 2000, Roos 1995). The BET monolayer value has been said to be optimal water 
content for stability of low-moisture materials (Labuza 1980, Roos 1995). The BET equation 
was developed based on the fact that sorption occurs in two distinct thermodynamic states; a 
tightly bound portion and multilayers having the properties of bulk free water (Zografi and 
Kontny 1986). 
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The BET model (Brunauer et al. 1938) is widely believed to give the best fit to the data at aw's 
of up to 0.5 (Bell and Labuza 2000, Roos 1995).  
( ) ( )( )WBW
WBm
aCa
aCmm
111 −+−=    (Eq. 4) 
where  
RT
HHkC LB
−= 1exp  
m is water content (g H2O / 100g dry material), mm is monolayer water content or monolayer 
capacity (g /100g dry material), aw is water activity (0-0.5) and CB is a energy constant, related 
to enthalpy of adsorption in the first adsorbed layer, H
B
]
1 is the heat of adsorption of the first 
vapour molecule adsorbed, HL is heat of condensation of the bulk adsorbate, T is the absolute 
temperature, R is the gas constant, k is a constant (after Kontny and Zografi 1995, Roos 1995, 
Timmermann 2003). 
 
Guggenheim-Anderson-de Boer (GAB) sorption model (Anderson 1946, de Boer 1953, 
Guggenheim 1966) introduces a third state of sorbed species intermediate to the tightly bound 
and free states. Even though the GAB model does not always accurately describe the moisture 
sorption phenomenon, this equation offers considerable practical utility in fitting isotherms for 
pharmaceutical materials to compare them with each other and to predict their behaviour over 
the entire RH range (Zografi and Kontny 1986). The GAB equation has a similar form to BET, 
but has an extra constant, K (Eq. 5). BET is actually a special case of GAB, with K=1.  
( ) ( )[ wGw
wGm
KaCKa
KaCmm
111 −+−=  (Eq. 5) 
where 
RT
HHDC mG
−= 1exp  
RT
HHBK mL −= exp  
CG and K are constants related to excess enthalpy of sorption, HL is heat of condensation of bulk 
adsorbate, Hm is the heat of adsorption of vapour adsorbed in the intermediate layer, H1 is heat 
of adsorption of the first vapour molecule, D and B are constants (after Kontny and Zografi 
1995, Roos 1995, Timmermann 2003) 
 
Isotherm equations are useful for predicting the water sorption properties of a material, but no 
equation gives results accurate throughout the entire range of water activities. According to 
Timmermann (2003), the GAB monolayer value is always higher than the BET monolayer value 
(). Prediction of water sorption is needed to establish water activity and water content 
relationship for materials (Roos 1995).  
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2.1.6 Hydrate formation 
Solids that form specific crystal hydrates first adsorb small amounts of water to their external 
surface (Kontny and Zografi 1995). On the addition of more water to the system, water will be 
sorbed so that the anhydrate crystal will be converted to the hydrate. The strength of the water-
solid interaction depends on the level of hydrogen bonding possible within the lattice (Zografi 
1988).  
 The hydration state of a crystalline hydrate is a function of the water activity above the 
solid (Morris 1999). A crystalline hydrate is a two-component system and is specified by 
temperature, pressure, and water activity. It is possible to classify the crystalline hydrates by 
structure: channel hydrates, isolated site hydrates, and ion-associated hydrates (Morris 1999). 
Ion-associated hydrates contain metal ion coordinated water, and the major concern with these is 
the effect of the metal-water interaction on the structure of crystalline hydrates. The dehydration 
temperatures are very high. 
 Channel hydrates contain water in lattice channels, where the water molecules included lie 
next to other water molecules of an adjoining unit cells along an axis of the lattice, forming 
channels through the crystal. Lattice channels could be divided into expanded channels and 
lattice planes. For example, crystalline theophylline is known to exist either as the anhydrate or 
monohydrate, which is channel hydrate. Packed crystals of theophylline monohydrate have 
relatively large channels or tunnels filled with water molecules (Byrn et al. 1999). The shape, 
size and number of the water tunnels, and the number and strength of hydrogen bonds between 
the solvent and the host compound may also play a role in preventing water molecules from 
escaping the crystals. During wet granulation of theophylline anhydrate incorporates water into 
the lattice and is transformed to theophylline monohydrate. When the wet theophylline granules 
are dried, the theophylline monohydrate either reverts back to the anhydrous form or is 
transformed to metastable anhydrous theophylline, which is a polymorph of theophylline 
anhydrate (Phadnis and Suryanarayanan 1997). The continuous dehydration is typically 
observed with the onset at relatively low temperatures for channel hydrates (Morris 1999). 
Dehydration of theophylline monohydrate occurs only if the crystals are heated to 35-50 °C or 
stored at low RH (Byrn et al. 1999). In their studies of water tunnels in theophylline 
monohydrate, Perrier and Byrn (1982) have shown that the water chain has a zigzag pattern. If 
the tunnel is zigzag, the cross-sectional area may be too small and may not accurately reflect the 
size of the tunnel. 
 Isolated site hydrates represent the structures with water molecules isolated from direct 
contact with other water molecules by intervening drug molecules (Morris 1999). For example, 
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crystalline nitrofurantoin has been found in four modifications of nitrofurantoin: anhydrous 
forms designated α and β, and monohydrous forms designated I and II (Pienaar et al. 1993a, 
1993b, Caira et al. 1996). Nitrofurantoin monohydrate form II belongs to isolated site 
monohydrates. Crystal packing in the β-polymorph of an anhydrous form of nitrofurantoin has a 
layer structure (Pienaar et al. 1993a). The molecular packing in nitrofurantoin monohydrate I 
shows a layer structure, whereas monohydrate II molecules have a herring-bone arrangement 
(Pienaar et al. 1993b). The water molecules play an essential role in stabilizing these 
arrangements through hydrogen bonding of nitrofurantoin monohydrate. Each water molecule in 
monohydrate II links two nitrofurantoin molecules by hydrogen bonding. For isolated site 
hydrates, dehydration temperatures are relatively high and the kinetics would be expected to be 
very rapid unless the structure collapsed and presented a barrier to the loss of the last water 
(Morris 1999). Nitrofurantoin monohydrate I has been shown to lose water more rapidly and at 
lower temperatures (104 °C) than nitrofurantoin monohydrate II (127 °C, Caira et al. 1996). 
Dehydration of nitrofurantoin monohydrate was changed to the amorphous form at 140 °C after 
loss of the water and collapse of the crystal structure, but at a higher temperature (200 °C) 
nitrofurantoin anhydrate was recrystallized (Karjalainen et al. 2005). Phase transformations of 
nitrofurantoin anhydrate with two excipients under high humidity conditions were reported 
earlier by Otsuka and Matsuda (1994). Phase transitions in nitrofurantoin formulations may take 
place during storage under adverse conditions of temperature and humidity as well as during a 
variety of processing conditions. Crystalline nitrofurantoin monohydrate, for instance, is stable 
in high humidity but is disrupted by mechanical stress, such as grinding, and transformed into a 
non-crystalline solid at low humidity (Kishi et al. 2002).  
 The potential pharmaceutical impact of changes in hydration state of crystalline API and 
excipients exists throughout the development process. The physico-chemical stability of the 
compound may be the main concern during preformulation (Morris 1999). Some hydrated 
compounds may convert to an amorphous form upon dehydration or compounds may convert 
from a lower to a higher state of hydration yielding forms with lower solubility and dissolution 
rates. Therefore, monitoring, identifying, and characterisation of crystal form is necessary 
during formulation. Excipients are important components of pharmaceutical formulations, and 
they can participate actively in improving the characteristics of formulations.  
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2.1.7 Comparison of water and nitrogen adsorption  
Adsorption methods are usually used to characterize dispersed or porous solids in relation to 
their processing, e.g. by adsorbent (Robens et al. 2004). The surface is subjected to adhering 
molecules and the extent of the surface and its structure are calculated by counting the 
molecules that are required to cover the surface or to fill a group of pores. The pore-size 
distributions calculated from the adsorption and desorption branches are substantially different. 
Problems appear if the pore structure varies due to the influence of the adsorbate, e.g. by 
swelling. Highly polar molecules cause a hydrophobic or hydrophilic effect, depending on the 
chemical nature of the solid surface (Robens et al. 2004). Larger apparent discrepancies between 
the water vapour and nitrogen BET surface areas for excipients was observed and it was 
suggested that the term specific surface area should not be used when water vapour sorption is 
involved (Zografi et al. 1984).  
 The amount of water that is sorbed into amorphous or partially amorphous substances 
(celluloses and starches) is larger than can be accounted for by surface adsorption (Zografi et al. 
1984). This is in contrast to adsorption in which the water taken up is dependent on the available 
surface area. The specific surface areas of microcrystalline celluloses (MCC) and starches 
measured by water sorption were higher than those measured by nitrogen adsorption. However, 
the specific surface areas of MCCs measured by nitrogen adsorption were higher than those of 
the starches. But the specific surface areas of MCC measured by water sorption were lower than 
the specific surface areas of starches. Differences in the apparent surface areas of celluloses and 
starches using nitrogen adsorption and water vapour sorption are not due to pre-existent pores, 
but instead to the penetration of water into the material and its specific interaction with 
individual anhydroglucose units (Zografi et al. 1984). Using pore analysis by nitrogen gas 
adsorption, it was shown that MCC does not contain the extent of intrinsic microporous 
structure that could account for the large apparent specific surface areas measured by water 
vapour sorption. Up to at least 6% moisture, sorbed water does not appear to influence the 
specific surface area of MCC and of starch up to about 10% moisture. Although water vapour 
sorption is reversible, the isotherm shows a hysteresis loop down to 0% RH (Robens et al. 
2004). But then water often tends to exhibit type III behaviour when adsorbed onto low energy 
surfaces, due to its strong intermolecular hydrogen bonding. Therefore it is not recommended 
that water be used as a probe molecule in BET surface determinations. Probe molecules of 
differing nature can show different adsorption mechanisms on the same solid surface. Water 
vapour is not suitable as a standard adsorbate for the investigation of surface structure, but the 
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isotherms give additional and quite different information on adsorption properties from that 
given by nitrogen isotherms (Robens et al. 2004). 
 
2.2 Oral solid dosage formulation 
2.2.1 Pharmaceutical development  
A pharmaceutical dosage form generally consists of a drug substance combined with a varying 
number of excipients that have been added to the formulation to facilitate its preparation and 
function as a drug delivery system. The principal objective of dosage form design is to achieve a 
predictable therapeutic response to a drug included in a formulation, which is capable of large 
scale manufacture with reproducible product quality. Preformulation studies have a significant 
part to play in anticipating formulation problems and identifying the limits and interactions 
between drug and excipients. Preformulation investigations are designed to deliver all the 
necessary data, which may influence formulation design, method of manufacture of drug 
substance and drug product, pharmacokinetic or biopharmaceutic properties of the resulting 
product, packaging of the product. In preformulation, relevant physico-chemical (e.g. 
crystallinity, hygroscopicity, salt selection, polymorphism, solubility, chemical and physical 
stability, compatibility), physico-mechanical (e.g. compactability) and biopharmaceutical (e.g. 
dissolution) properties of drug substances, excipients and packing materials are characterized to 
ensure product quality.  
 Almost all new drugs which are active orally are marketed as tablets, capsules or both. A 
common problem in the preformulation of oral solid dosage forms is the optimisation of the 
excipient mixture composition which is intented to prepare a product with the required 
characteristics (Campisi et al. 1998). Drug-excipient interaction study at an early stage of 
product development is an important exercise in the development of a stable dosage form 
(Verma and Garg 2004).  
 
2.2.2 Excipients 
Pharmaceutical excipients are substances other than the pharmacologically active drug or 
prodrug which are included in the manufacturing process or are contained in a finished 
pharmaceutical product dosage form. Although excipients are considered to be inert in 
therapeutic or biological actions, they should hinder unwanted phase transitions and ensure the 
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required stability of the drug in the formulation during the manufacturing process and storage. 
The International Pharmaceutical Excipients Council (IPEC) has defined pharmaceutical 
excipients as any substance other than the active drug or prodrug which has been appropriately 
evaluated for safety and are included in a drug delivery system to either 1) aid processing of 
system during its manufacture, or 2) protect, support or enhance stability, bioavailability, or 
patient acceptability, or 3) assist in product identification, or 4) enhance any other attribute of 
the overall safety and effectiveness of the drug during storage or use.  
 Pharmaceutical excipients for solid dosage forms are classified (IPEC) according to the 
function they perform in a pharmaceutical dosage form, although many excipients perform 
multiple functions. Principal excipient classifications according to their functions are the 
following: 
• Binders 
• Disintegrants  
• Fillers (diluents)  
• Lubricants  
• Glidants (flow enhancers)  
• Compression aids  
• Colours  
• Sweeteners  
• Preservatives  
• Flavours  
• Film formers/coatings  
• Printing inks  
• Suspensing/dispersing 
agents/surfactants  
 
The most common formulations include drug substance, a filler, a disintegrant and a lubricant, and 
occasionally glidants, colourants and wetting agents may also be included (Davies 2001). The 
quality of the final product will be as dependent on the way in which the components are combined 
as it is on the components selected.  
 There is constant pressure to search for new excipients to attain the desired set of 
functionalities (Nachaegari and Bansal 2004). Novel mixtures and new physical forms of excipients 
are developed and tailored to the needs of newer delivery stage, e.g. oral modified release (Joshi 
2004). The reasons for looking for new excipients are e.g. 1) a new drug with varying physico-
chemical and stability properties, 2) a demand for an ideal filler-binder that can substitute two or 
more excipients, 3) requirements for excipients to maintain good compressibility and low weight 
variation even at short dwell times, 4) shortcomings of excipients such as high moisture sensitivity, 
5) the lack of excipients that address the needs of a specific patients such as those with diabetes, 
hypertension and lactose and sorbitol sensitivity, 6) the ability to modulate the solubility, 
permeability, or stability of drug molecules, 7) the growing performance expectations for excipients 
to address issues such as disintegration, dissolution, and bioavailability (Nachaegari and Bansal 
2004).  
 18
THEORY AND REVIEW OF THE LITERATURE 
___________________________________________________________________________ 
 Improved functionality of excipients can be obtained by developing new chemical excipients, 
new grades of existing materials, and new combinations of existing material (Moreton 1996). Most 
excipient manufacturers concentrate on modifying existing excipients instead of developing 
completely new ones, because excipient discovery and development is relatively expensive 
(especially testing toxicity) and time-consuming. The excipient should comply with pharmacopoeial 
requirements, be globally acceptable and meet the proposed design specification (Davies 2001). 
Developing new grades of existing excipients has been the most successful strategy for the 
development of physico-chemical new excipients, such as pregelatinized starch (Shangraw and 
Wallace 1981, Nachaegari and Bansal 2004). A greater knowledge can be developed about the 
characteristics of excipients which have been widely used. The final manufacturing of solid dosage 
forms is easier and faster if the excipients are already in the stock and the release specifications and 
limited assortment is reduced options of excipient choice in the new formulation (Davies 2001).  
 Excipient functionality could be improved with new combinations of existing excipients, 
because all formulations contain multiple excipients (Nachaegari and Bansal 2004). High-
functionality and multifunctional (two or more functions through a single ingredient) excipients 
have been developed by providing simplified formulations; they have high inherent functional 
performance allowing for increased batch sizes and higher drug-loading; and they impart their 
inherent performance characteristics to the overall formulation (Zeleznik and Renak 2004). The use 
of high functionality excipients results in better products, lower costs, shorter time to market, and 
extended product lifecycle (Sherwood 2003). For example, silicified microcrystalline cellulose 
(SMCC) demonstrates the high functionality of multiple excipients: it could be used in the 
formulation as lubricant, filler and disintegrant.  
 Excipients should play a key role in turning an unstable drug into an acceptable product. 
Fundamentally unstable drugs can be transformed into viable medicinal products by formulating 
with appropriate excipients that have some direct effect on the molecular integrity of the API 
(Crowley 1999). It might be necessary to consider developing a formulation that compensates for 
any basic deficiencies in the stability of the drug substance. During product optimization, excipients 
should be selected based on a variety of acceptance criteria (Davies 2001). When developing 
successful formulation, it is important to understand the API, the excipients and the process, and in 
particular, their limitations.  
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2.2.3 Manufacturing process 
Granulation phase 
Granulation is the process in which small particles are made to form larger, physically strong 
agglomerates in which the original particles can still be identified. In the majority of cases this will 
be used in the production of tablets or capsules, when granules will be made as an intermediate 
product, but granules may also be used as a dosage form. The manufacturing process of solid 
dosage forms is presented schematically in Fig. 6. The general reasons for granulation is to prevent 
segregation of the constituents in the powder mix, to provide better control of drug content 
uniformity at low drug concentrations, to improve the flow properties of the mix, to improve the 
compression characteristics of the mix, to make the surface of particles and the tablet hydrophilic 
and to reduce the harmful toxic dust (Summers 1988, Augsberger and Vuppala 1997, Faure et al. 
2001).  
API
Mixing phase
Excipients
Drying phase
Granulation phase
Granulation
liquid
Tableting
Excipients
Coating
Final solid
dosage form
Mixing
Excipients
 
Figure 6. Schematic presentation of 
different stages during manufacturing 
process of solid dosage forms.  
 
Wet granulation is most widely used manufacturing process in the pharmaceutical industry. In 
general wet granulation is done using a binder liquid consisting mostly of water and some polymer. 
The particle growth occurs by liquid bridging of powders and when water evaporates, the binder 
solidifies between the particles, forming a strong solid bond (Newitt and Conway-Jones 1958). 
These bonds must be sufficiently strong to prevent breakdown of the granule to powder in 
subsequent handling operations (Summers 1988). The mechanisms of bonding in the wet state 
depend on capillary and viscous interparticle fluid forces or interfacial forces between particles 
(Augsberger and Vuppala 1997). During wet granulation each state of liquid content in the 
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agglomerate represents a progressive increase in the moisture content, with a corresponding change 
in capillary forces. In practice, more than one bonding mechanism may be acting simultaneously.  
 Accoding to Iveson et al. (2001) wet granulation behaviour could be determined by three sets 
of rate processes: 1) wetting and nucleation; 2) consolidation and growth; and 3) breakage and 
attrition. Wetting and nucleation is the process of bringing liquid binder into contact with dry 
powder and trying to distribute this liquid uniformly throughout the powder to give a distribution of 
nuclei granules. Whenever material in the granulator collides and sticks together granule growth 
occurs. Two large granules can be united to form a larger granule or fine material can be stuck onto 
the surface of large pre-existing granules. When granules collide with other granules and equipment 
surfaces they gradually consolidate and this reduces their size and porosity. The granules gradually 
consolidate during agitation, and that increases their liquid pore saturation and alters their 
mechanical properties. Granule consolidation and liquid saturation might depend strongly on the 
formulation and binder properties. Breakage of wet granules will influence and may control the 
final granule size distribution. Attrition of dried granules leads to the production of dusty fines.  
 Typically wet granulation processing takes place in one of two types of closed granulating 
systems: fluid bed granulators or high-shear mixers (Faure et al. 2001). The properties of the 
granule are influenced by the manufacturing process, e.g. the granules formed in high-shear mixers 
are harder and denser than those obtained in fluid bed granulation. Predicting the appropriate 
amount of water added to powders is important but difficult, since suitable moisture content varies 
with pharmaceutical formulations, due to powder properties. The amount of liquid required for a 
wet granulation process depends on a large number of factors, such as material properties, liquid 
characteristics and the mode of action of the equipment (Kristensen and Schaefer 1987). For 
example, a crystalline substance can be dissolved in the granulating solution during the wet massing 
phase. The size of crystals produced in the recrystallization could be changed from original. This 
may modify the dissolution rate and drug bioavailability. According to Mackaplow et al. (2000) dry 
lactose granule size distribution was more dependent on the amount of added water than the 
primary particle size. This was due to the increased size and number of recrystallized lactose 
bridges holding the dried lactose particles together.  
 
Drying phase 
In wet granulation drying or dehydration is a process which consists in removing part of the water 
contained from a solid by thermal methods to obtain the moisture level best suited to the subsequent 
process (Terrier de la Chaise and LePerdriel 1972). Drying is essentially a process of simultaneous 
heat and mass transfer. Heat, necessary for evaporation, is transferred from the surroundings to the 
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particle surfaces by convection and from there further into the particle by conduction. On the 
surface water evaporates and passes on by convection to the surroundings. The three most common 
drying methods for pharmaceutical granules are tray drying, fluid-bed drying, and vacuum drying 
(Van Scoik et al. 1993). In tray drying the wet granules are placed on trays, which are moved into a 
drying oven. The particles are positioned in a static bed and hot gas or air is circulated over the 
granulation bed, and then drying can take place only from the upper surface of the bed. In tray 
drying, bed thickness is important, and the drying of wet granules is a function of the properties of 
the bed (Carstensen and Zoglio 1982). The drying is primarily from the bed surface and the vapour 
diffusion is drying rate determining. A fluid-bed drying is obtained when the wet granules are 
supported in an expanded state by gases moving up through the bed. Typically during a fluid bed 
drying process, water loss occurs in two stages: heat-transfer limited and mass-transfer limited 
phases (Wildfong et al. 2002). During the heat-transfer limited phase the air temperature 
surrounding the material is reduced as water evaporates from the wet surface of particles in the bed, 
and the rate of drying and the bed temperature remain constant. During the mass-transfer limited 
phase, drying occurs when water evaporates from the surface and the remaining water diffuses to 
the surface of the granules.  
 In the drying phase the first water molecules evaporate from the surfaces of particles and 
water remained within the particle must then diffuse towards the surface of the wet mass (granules) 
before it can be evaporated. The drying cycle for all solids can be divided into three distinct phases: 
a heating phase, a constant rate of evaporation phase, and a falling rate of evaporation phase 
(Cooper et al. 1961, Terrier de la Chaise and LePerdriel 1972). The heating phase is quite short and 
during this phase equilibrium is attained between the wet solid and the drying air (Brennan 2003). 
The rate of drying is constant since the surface of solid remains saturated with water, and water is 
drawn to the surface by capillary forces (Terrier de la Chaise and LePerdriel 1972). The rate of 
movement of water to the surface of solid is larger than the rate of water evaporation from surface. 
In a tray drying system, if the granules are tightly packed, air cannot take the place of water, and 
capillary forces play only a minor role and moisture moves by diffusion. Falling rate phase starts, 
when movement of moisture within the material is not sufficient to keep the surface saturated and 
the surface starts to dry out. Finally, the moisture content of granules reaches a thermodynamic 
equilibrium with the surrounding air (Hlinak and Saleki-Gerhardt 2000).  
 Dehydration reactions are influenced by a number of factors, including crystal packing, 
humidity and temperature, but hydrogen bonding and tunnel areas inside the crystals are the two 
most important factors (Byrn et al. 1999; Sun et al. 2002). Granules and crystalline solids should be 
relatively easy to dry due to the extensive distribution of water within the capillaries and the large 
 22
THEORY AND REVIEW OF THE LITERATURE 
___________________________________________________________________________ 
water tunnels (Terrier de la Chaise and LePerdriel 1972). The internal water of amorphous solids 
transfers slowly, because the remainder of water diffuses out through the solid. The shape, size and 
number of the water tunnels, and the number and strength of hydrogen bonds between the solvent 
and the host compound may also play a role in preventing solvent molecules from escaping the 
crystals (Byrn et al. 1999). The strength of the water-solid interaction depends on the level of 
hydrogen bonding possible within the lattice (Zografi 1988, Kontny and Zografi 1995). Desorption 
isotherms could be used to determine the rate and extent of drying or dehydration phase. 
 
 
2.3 Physical stability of solid dosage forms 
Solid-state forms affect solubility and dissolution rate and the use of amorphous, different 
polymorphs or solvates can affect the bioavailability (Huang and Tong 2004). Although 
pharmaceutical amorphous solids often have desirable properties, like faster dissolution rates, than 
their crystalline counterparts, they are not marketed as widely as the crystalline forms because of 
their lower chemical stability and their inherent tendency to crystallize (Vippagunta et al. 2001). 
Thus, most marketed pharmaceutical solids consist of molecular crystals (Yu et al. 2000, Datta and 
Grant 2004). To develop a pharmaceutically acceptable, stable formulation, instabilities within the 
API or excipient must be explored and stabilized. By investigating the intrinsic stability of the drug, 
it is possible to advise on formulation approaches and indicate types of excipient, specific protective 
additives and packing which are likely to improve the integrity of the drug and product. As using 
inhibitors like excipients in the formulation, it would be desirable to avoid as many phase 
transitions as possible (Morris et al. 2001).  
 
2.3.1 Processing-induced transformations (PITs) 
Pharmaceutical solids that exist in different physical forms, crystalline or amorphous, offer unique 
challenges in product development and manufacturing processes (Morris et al. 2001, Murphy et al. 
2002). Process-induced transformations (PITs) are phase transformations which occur as a result of 
mechanical or thermal stress imposed upon a system during manufacturing processing or after 
exposure to solvent (Brittain and Fiese 1999, Wikström et al. 2005). PITs include the production of 
amorphous regions, crystallization of amorphous material, polymorphic transformations, changes in 
size and shape of materials, dehydration of crystalline hydrates, and hydration of anhydrous crystals 
(Morris et al. 2001). Manufacturing processes that may facilitate a PIT are e.g. grinding, wet 
granulation, drying and tableting (York 1983, Byrn et al. 1999, Morris et al. 2001). These PITs are 
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well known but difficult to predict and often difficult to control (Morris et al. 2001). Thus it is 
important to determine whether phase transformations occur, in order to understand the mechanism 
and kinetics of phase transformations and factors that may influence them and finally control them 
during manufacturing processes (Rodríguez-Hornedo and Wu 1991, Morris et al. 2001, Wikström et 
al. 2005). During the processing of pharmaceutical solids the most important phase transitions are 
1) transformation, like polymorphic transformations, crystallization of the amorphous form and vice 
versa, incongruent melting (melting followed by crystallization of a more stable form), solution-
mediated polymorphic transformations; 2) physical interactions, like the formation of eutectic 
mixture or solvate/hydrate formation; 3) physical decompositions, like desolvation (Morris et al. 
2001).  
 Polymorphism is often characterized as the ability to exist as two or more crystalline forms of 
the same compound that have different arrangements and/or conformations of the molecules in the 
crystal lattice (Grant 1999). Different polymorphs or pseudopolymorphs have different physical 
properties e.g., powder flow and compactability, solubility and dissolution rate that relate to 
stability and bioavailability. Generally, the unsolvated form has better dissolution behaviour than 
the hydrate/solvated form. It is often difficult to formulate a bioequivalent drug product using a 
different polymorph. Therefore the most stable polymorphic form of a material is often used 
because it has the lowest potential for conversion from one polymorphic form to another, while the 
metastable form may be used to enhance the bioavailability. However, a metastable pharmaceutical 
solid form can change crystalline structure or solvate or desolvate in response to changes in 
environmental conditions, processing, or over time. It is necessary to ensure that polymorphic 
differences (when present) are addressed via design and control of formulation and process 
conditions to physical and chemical stability of the product over the intended shelf-life, and 
bioavailability or bioequivalence. Changing the temperature or pressure during a manufacturing 
operation, such as tableting, could induce a polymorphic transformation (Byrn et al. 1999) 
 Because an amorphous form is thermodynamically less stable than any crystalline form, 
inadvertent crystallization from an amorphous drug substance may occur. Amorphous material 
could crystallize e.g. during storage, especially on exposure to heat and humidity (Yu 2001). The 
combination of solvent and drying conditions provides a suitable environment for the generation of 
new polymorphs (Brittain and Fiese 1999). The crystalline unsolvated drug will likely form a 
hydrate during wet granulation, but the hydrate formed could also convert to another unexpected 
form upon drying (Phadnis and Suryanarayanan 1997, Newman and Byrn 2003). Whenever a wet 
suspension containing a drug substance is dried, the possibility exists that a change in its crystal 
state will take place. When a particular physical form is selected for formulation, ensuring that this 
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form in the final product remains unchanged is critical. Monitoring of the solid-state form during 
the manufacturing process is especially important if dissolution or stability of the product is 
sensitive to solid phase changes (Zhang et al. 2004).  
 
2.3.2 Moisture-induced phase transitions  
Since API and excipients in the formulation may have different moisture sorption properties, they 
can interact and produce unpredicted PITs. The interaction of moisture with pharmaceutical solids 
is highly crucial to an understanding of water-based processes, e.g. manufacturing processes or 
prediction of solid dosage form stability and shelf-life (Ahlneck and Zografi 1990, Hancock and 
Zografi 1997). At the same time, since moisture sorption by amorphous and crystalline materials is 
usually quite different, this can be utilized when designing dosage formulation.  
 During the wet granulation process the both wetting phase solvent and drying phase 
conditions can cause a suitable environment for the transformation to alternate crystalline forms 
(Wong and Mitchell 1992, Davies et al. 2004). Polymorphic transformations during wet granulation 
can be divided to 1) conversion of a metastable form to the stable form; 2) conversion of the stable 
form to a metastable form; or 3) conversion of an unsolvate form to a solvate form (Morris et al. 
2001). These solvent-mediated polymorphic phase transformation involves the dissolution of the 
metastable form and growth of nuclei of the stable phase (Cardew and Davey 1985, Murphy et al. 
2002). The kinetics of the possible phase changes, like hydrate formation, determines whether or 
not the changes will be complete during the time scale of the process. As a consequence of the 
higher mobility and ability to interact with moisture, amorphous drug substances are also more 
likely to undergo solid-state reactions. The time required for the disappearance of the metastable 
phase, that is the total time of solvent-mediated phase transformation, is given by the sum of the 
characteristic times for the dissolution and growth processes (Cardew and Davey 1985). The growth 
and dissolution processes are balanced at some stage in the process.  
 Metastable forms are expected to dissolve more rapidly than their corresponding stable forms 
(Depnath and Suryanarayanan 2004). However, a metastable form could also transform from the 
metastable to the stable form in the dissolution medium and thus the dissolution rate could be much 
lower than the predicted values. Because the solubility of the metastable form is determined by 
kinetic processes, it is dependent on the variables that control dissolution and crystallization rates: 
solubility, interaction between solute and solvent molecule, total solid surface area (mass and 
specific surface area), hydrodynamic conditions and temperature (Murphy et al. 2002). Besides 
during processing, during storage or dissolution metastable forms can also crystallize and transform 
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to a more thermodynamically stable form (Byrn et al. 1995, Zhu et al. 1996, Rodriguez-Hornedo 
and Murphy 1999). Davies et al. (2004) presented a theoretical model for solution-mediated 
transformations during wet granulation. The transformation of a stable to metastable form would 
not be expected to occur during the wetting phase of a wet granulation. However, after wetting, the 
amount of material in solution may be trapped as the metastable form. And if the drying rate is 
much faster than the solution-mediated transformation of the metastable to stable form, the 
metastable polymorph may crystallize as drying progresses: the faster the wet granules were dried, 
the more metastable polymorph would be formed by kinetic trapping.   
 
2.3.3 Temperature-induced phase transitions  
Temperature affects the mobility of water molecules and the equilibrium between the moisture and 
the adsorbed phases (Barbosa-Cánovas and Vega-Mercado 1996). An increase in temperature, at 
constant RH, causes a decrease in the amount of adsorbed water. An exception to this is shown by 
some sugars that dissolve in water and become more hygroscopic at higher temperatures. At the 
same time, an increase in moisture content, temperature and/or time of heating could result in 
increases in colour development for some sugars. In the Maillard non-enzymatic browning reaction 
an amine group reacts with a reducing sugar (like lactose) to form a glycosyl amine and forms 
brown-coloured degradation products (Hartauer and Guillory 1991, Wirth et al. 1998). The Maillard 
reaction occurs most rapidly at intermediate aw values (0.5-0.8).  
 Amorphous solids are generally less stable physically than their corresponding crystals (Yu 
2001). The important factor is the Tg, above which the molecular mobility and the rate of solid-state 
reactions increase significantly (Yu et al. 2000). For example, when native starch granules are 
heated in excess water, phase transitions of starches are observed (Roos, 1995). The gelatinization 
of starch granules is governed by moisture content and temperature, typically in the range of 60-
85°C (Whistler and BeMiller 1997, Fukuoka et al. 2002). When undamaged native starch granules 
absorb water through hydrogen bonding with their free hydroxyl groups, they swell, but they still 
retain their order and crystallinity and then return to their original size on drying. If these swollen 
maize starch granules are heated, intermolecular hydrogen bonds are disrupted and the crystallinity 
is gradually destroyed. Continued heating of starch granules in excess water results in further 
granule swelling (and eventually their disruption) and viscosity development. During cooling or 
dehydration, some starch molecules begin to reassociate in an ordered structure, forming a 
precipitate or gel, or recrystallize slowly (Whistler and BeMiller 1997). Jouppila et al. (1998) 
observed that maize starch was crystallized into the same crystal form, independent of water content 
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and storage temperature, but the rate of crystallization in starch was found to increase with 
increasing storage temperature. Crystallization of amylopectin in starch gels often occurs during 
storage at a rate depending on the water content and storage temperature, and crystallization can 
occur at temperatures above the Tg (Roos 1995). 
 
2.3.4 Monitoring of phase transitions 
Advances in pharmaceutical materials and processing require new pharmaceutical technologies or 
an improved understanding and monitoring of each step from raw material qualification to final 
product release during dosage form 
development (Morris et al. 1998). Process 
Analytical Technologies (PAT) are systems for 
design, analysis, and control of manufacturing 
processes based on timely measurements of 
critical quality and performance attributes of 
raw and in-process materials and processes to 
reach the desired or optimum product (FDA 
2004). Methods of PAT are based on scientific 
and engineering principles for evaluating and 
diminishing risks related to poor product and 
process quality (Yu et al. 2004). Monitoring 
provides new understanding, and knowledge of 
critical control points, facilitates better control 
and predictability of process variation and thus 
assures high quality and performance attributes of raw materials, in-process materials, and final 
products (Newman and Byrn 2003, Yu et al. 2004). A desired goal of PAT is to design and develop 
processes that can consistently ensure a predefined quality at the end of the manufacturing process 
(FDA 2004). Such proceeding would be consistent with the basis principle of quality by design and 
could reduce risks to quality and regulatory concerns while improving efficiency. In addition other 
aims of PAT are to reduce reject products, shorten manufacturing time, increase automation to 
reduce human error, deliver significant improvements in quality consistency, avoid batch-to-batch 
variation and reduce costs. Raw material qualification is an important part of process validation, 
because variation in raw materials can lead to failures in production and/or dosage form 
I Molecular level: II Particulate level
Ultraviolet/visible 
diffuse reflectance 
spectroscopy
Optical and electron 
microscopies
Vibrational 
spectroscopy         
(IR, NIR, Raman)
X-ray diffraction
Magnetic resonance 
spectrometry (NMR)
Thermal methods of 
analysis                
(DTA, DSC, TG)
Table 1 Examples of methods used for characterizing 
and monitoring of phase transitions in the formulation 
(modified from Brittain et al. 1995) 
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performance attributing batch-to-batch variation and failed batches (Morris et al. 1998). The data 
collected in-line during the manufacturing steps will decrease post-production analysis through an 
improved understanding of the manufacturing processes (Newman and Byrn 2003).  
 For example, several methods are used for characterizing and for routine off-line testing of 
pharmaceutical solid polymorphs: X-ray powder diffraction (XRPD), microscopy, thermal analysis, 
and spectroscopy (Table 1). Vibrational spectroscopies like Raman and near-infrared (NIR) 
spectroscopies can be used to monitor kinetic processes of polymorphic systems in real-time. PAT 
methods are sensitive to solid form, such as determining a phase transition during a wet granulation 
process, and sensitive to hydration, such as determining the drying endpoint for a granulation in a 
fluid dryer with NIR (Newman and Byrn 2003). PAT should be utilized in pharmaceutical 
development, manufacturing processes and quality control to improve the formulation design and 
process development and minimize process-induced phase transitions in formulation (Grant and 
Byrn 2004). This improved control will rely on a better characterisation and understanding of 
excipients and the properties that affect their role in the formulation and the manufacturing process 
(Moreton 2004). However, process functionality and a final dosage form may not be the same thing: 
PAT relates to process monitor and control, not a final dosage form.  
 
2.3.5. Effects of excipients on the physical stability of the formulation 
Excipients can interact with an API or another excipient affecting the absorption and bioavailability 
of the product. Therefore, each excipient must be shown to be compatible with the formulation and 
pack and efficiently perform its desired function in the product (Jackson et al. 2000). However, it is 
not known precisely why some materials behave in certain ways when included in a formulation 
(Moreton 2004). Instability of APIs and excipients may be broadly classified as chemical (like 
hydrolysis, oxidation and deamidation) or physical instability (like polymorphism, 
pseudopolymorphism or crystallization). Many APIs in the solid-state undergo significant physico-
chemical change in the presence of certain solid excipients: an increased rate of chemical 
degradation; a reduction in the degree of crystallinity; and the formation of molecular complexes 
(Ahlneck and Zografi 1990, Huang and Tong 2004). Metastable crystalline polymorphs may be less 
chemically stable than the most physically stable crystalline form (Singhal and Curatolo 2004). The 
factors that could cause the molecular transformation of API in the formulation include: 
environmental components, such as water vapour and sunlight; stresses during conversion to the 
dosage form, such as a compaction process; or interactions between adjacent molecules of API or 
between functional groups on the same molecules (Crowley 1999). Optimizing the selection of 
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excipients in the formulation could reduce PITs during manufacturing and storage of final dosage 
forms (Zografi 1988).   
 The amorphous character is common in the polymeric molecules used as excipients. For 
example, sugars usually exist in the amorphous state e.g. as a result of milling, spray drying or 
freeze drying (Hancock and Shamblin 1998). Amorphous sugars are highly hygroscopic and at high 
RHs they may sorb large amounts of water causing crystallization of that sugar. This process can 
have significant consequences for the stability of pharmaceutical formulations, because the presence 
of only small amounts of amorphous material can affect the interaction between the powder and 
other components of a formulation (Buckton and Darcy 1995). Moreover the crystalline form of the 
API or excipient can markedly affect its solubility. For example amorphous solids have higher 
dissolution rates than their corresponding crystals (Yu 2001). On the other hand, the aqueous 
solubility of an anhydrate is greater than that of its hydrate form at temperatures at which the 
hydrate crystallizes from water (Khankari and Grant 1995). 
 Solid-solid reactions comprise an important aspect of the stability of formulations (Byrn et al. 
2001). To understand the influence of formulations on solid-state reactions, we should know 
basically what kind of reactions can occur in API and formulations. Drug-excipient interactions 
might not be expected and might adversely affect the bioavailability, stability and shelf-life of the 
formulation (Crowley 1999, Jackson et al. 2000, Cavatur et al. 2004, Huang and Tong 2004). 
Interactions occur more frequently between excipient and API than between excipient and excipient 
(Serajuddin et al. 1999, Pifferi and Restani 2003, Cavatur et al. 2004). Solid-state reactions include 
solid-state phase transformations (polymorphic transformation), reactions in which the solvent of 
crystallization is lost and solid-state chemical reactions (such as transacylation, Maillard browning 
reaction and acid-base reactions) (Hartauer and Guillory 1991, Wirth et al. 1998). The most 
significant physico-chemical changes in the solid state are an increased rate of chemical degradation 
(Cartensen 1988); a reduction in the degree of crystallinity; and the formation of molecular 
complexes (Crowley 1999, Jackson et al. 2000). The formulation can also accelerate the 
degradation or transformation of API. Acceleration could be due to an interaction with excipients, 
or it due to processing effects, or acceleration is induced by excipients, but not involving chemical 
reactions with the excipient. Often acceleration of the reaction is due to the presence of amorphous 
material (Byrn et al. 2001). Otsuka and Matsuda (1994) reported that α-lactose monohydrate 
(LMH) could accelerate hydrate formation of API in the formulation during storage at 95% RH at 
40°C. In contrast MCC in the formulation did not change the physical form of the API. The 
mixtures of deliquescent API-excipient started deliquescence at a lower RH, because mixtures were 
more hygroscopic in nature than the API and excipient alone (Salameh and Taylor 2005). Thus, 
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lowering of the deliquescence RH in API-excipient systems could have potential implications for 
the physical and chemical stability of the dosage form that will be dependent on composition, 
storage RH and temperature.  
 An excipient’s effect depends on the amount present, and hence, the amount of moisture it 
brings into the drug-excipient interaction, as well as the relative ability of each solid to uptake and 
retain water at a particular temperature and RH (Herman et al. 1989, Ahlneck and Zografi 1990).  
Sugars, for example, are widely used pharmaceutical excipients in solid and liquid dosage forms, 
and they can interact strongly with moisture due to their hydrophilic nature (Hancock and Shamblin 
1998). Sorbed moisture can markedly change the physical and chemical properties of 
polysaccharides by accelerating hydrolytic degradation, isomerization and/or crystallization 
processes, and by affecting the flow and compaction properties of polymer and the physical and 
chemical stability of solid dosage forms (Alvarez-Lorenzo et al. 2000, Zhang et al. 2004). It is 
advantageous if the hygroscopicity of a formulation can be predicted at an early stage of 
formulation development. Certain excipient properties may relate to the functionality of a particular 
formulation and manufacturing process in a more general sense and can be controlled (Moreton 
2004). The interaction of moisture with pharmaceutical solids is highly crucial to an understanding 
of water-based processes, e.g. manufacturing processes or prediction of solid dosage form stability 
and shelf-life. With PAT initiative, better-controlled products should result from improving control 
over the process. This will pass on a better characterisation and understanding of excipients and the 
characteristics that affect their performance in the formulation and the process. The selection of 
excipients for the formulation can control PITs and affect the storage stability of the final dosage 
form. 
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3. AIMS OF THE STUDY 
The broad objective of this thesis was to study the effect of water on different excipients and 
explain the water-excipient-API interactions with special regard to the formulation and 
manufacturing of solid forms.  
 
The specific aims were: 
1) to investigate the moisture sorption properties of various excipients with different degree of 
crystallinity in relation to preformulation stage (Paper I) 
2) to characterize differences between the selected excipients in controlling the physical 
stability of formulations (Papers I to IV) 
3) to study effect of crystalline or amorphous excipients on hydrate formation of the model API 
during wet granulation and storage (Papers II to IV) 
4) to investigate the hydrate formation kinetics of model API (Paper IV) 
5) to examine the use of spectroscopic methods as tools to identify and to monitor hydrate 
formation and dehydration in the formulations containing excipients (Papers I to V)  
6) to compare and to evaluate physical stability of both model API and excipients in the 
formulation during heating or drying process using different drying conditions and 
techniques (Papers I, III and V)  
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4. EXPERIMENTAL 
Detailed descriptions of the materials and methods can be found in the respective papers (I-V). 
 
4.1 Materials (I-V) 
Theophylline anhydrate (Orion Pharma, Espoo, Finland) (Papers II, IV, V) and nitrofurantoin 
anhydrate (Sigma-Aldrich Chemie, Steinheim, Germany) (III) were selected as a hydrate-forming 
model drugs. To obtain reference hydrates, theophylline anhydrate (II, IV and V) and nitrofurantoin 
anhydrate (III) were dissolved in purified water at 60 °C. Needle-like monohydrate crystals were 
obtained by slow cooling of the solution. A total of 13 different excipients were used in this study 
(Table 2 modified from paper I).  
 
Table 2. Some physical properties of excipients used in the study 
 
Excipient  (Manufacturer) Brand name
Average particle 
size (µm)        
d50 (d10-d90) 
Specific 
surface area 
(m2/g)
Paper, where 
excipient 
studied
L-hydroxypropylcellulose (LHPC) grade LH-11 (LHPC1) 57 (13-173) 0.99 I
(Shin-Etsu Chemicals Co.,Ldt., grade LH-21 (LHPC2) 54 (12-136) 0.97 I, III
 Tokyo, Japan) grade LH-30 (LHPC3) 18 (4-54) 1.93 I
α-Lactose monohydrate (LMH) Pharmatose® 200M 43 (5-127) 0.52 I, II, III, IV
(DMV International, Veghel, Netherlands)
Maize starch (STA) 17 (9-35) 1 I
(Maydis amylum, Cerestar, Scandinavia)
D-Mannitol (MANN) Mannitol® 60 46 (9-135) 0.33 I
(Roquette freres, Lestrem, France)
Microcrystalline cellulose Avicel® PH 101 (MCC1) 57 (18-127) 1.21 I
(FMC International, Cork, Ireland) Avicel® PH 102  (MCC2) 113 (31-209) 1.24 I
Avicel® PH 200 (MCC3) 196 (52-330) 1.17 I
(JRS Pharma, Nastola, Finland) Emcocel® 50 (MCC4) 63 (21-133) 1.37 I
Silicified microcrystalline cellulose ProSolv® 50  (SMCC1) 56 (18-121) 5.63 I, II, III, IV
(JRS Pharma, Nastola, Finland) ProSolv® 90HD (SMCC2) 121 (38-207) 6.48 I
Starch, pregelatinised (PGSTA) Sta-rx® 1500 72 (17-157) 0.26* I, III
(Colorcon, Indianapolis, USA)  
 
 
*Handbook of Pharmaceutical Excipients (Kibbe, 2000) 
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4.2 Characterisation of materials (I-V) 
The specific surface area was measured (Paper I) using the nitrogen-adsorption technique based on 
the BET theory (TriStar 3000, Micromeritics Inc., Norcross, GA, USA). The specific surface area 
was calculated according to the current United States Pharmacopoeia (USP) version. The 
morphology of the samples was studied based on micrographs taken with a SEM (Scanning 
electron microscope JSM-840A, Jeol, Tokyo, Japan). The sample preparation for electron 
microscopy was done according to the current USP version. Moisture contents were determined by 
Karl Fischer titration (II) (Mettler Karl Fischer titrator, DL35, Mettler Toledo AG, Geifensee, 
Switzerland). Measurements were made in triplicate. The volume particle size distribution (III) was 
determined by a method based on laser light diffraction (Laser Diffraction Particle Size Analyser 
LS13 320, Beckman Coulter Inc., Miami, USA).  
 
4.3 Processing of materials  
4.3.1 Wet granulation (I, II, IV, V) 
All studied 13 excipients (I) were granulated with that amount of water, which each excipient could 
uptake without forming of hydrate of APIs. The water amounts used varied from 0.1 to 4.5 g/g 
depending on the excipient and this amount was based to the results of paper III.  
 Wet masses of anhydrous theophylline (II, IV, V) were performed using a planetary mixer 
(Kenwood KM400, Kenwood Ltd., UK). The granulations were carried out by adding varying 
amounts of water to the dry material using a pump. The water amounts used were 0.03 g, 0.07 g, 
0.1 g and 0.2 g (II); 0.1 g (IV) or 0.5 g (V) water per 1 g of anhydrous theophylline. The masses 
were mixed for 5 min (II, V) or 2-3 min (IV) after the addition of water. Nitrofurantoin anhydrate 
(III) was granulated with water addition of 0.1 g/g, 0.2 g/g and 0.3 g/g to the dry materials and the 
granulations were performed with a mortar and pestle to simulate the early stages of 
preformulation. The wet masses were stirred thoroughly and packed in tightly sealed plastic bags 
until analysis (II, III) to ensure a uniform distribution of water and to minimize evaporation of 
water. The wet masses were studied on the first day (III) and on the second day (II, III) after an 
overnight equilibration in plastic bags at +5 °C (II) or at room temperature (III).  
 Wet masses of anhydrous theophylline (II, IV) or anhydrous nitrofurantoin (III) and 1:1 (w/w) 
mixtures with the excipients were granulated using a planetary mixer (II, IV) or with a mortar and 
pestle (III). The water amounts used were 0.03 g/g, 0.07 g/g, 0.1 g/g and 0.2 g/g (II); 0.1 g/g (IV) or 
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varying amounts (0.1-4.5 g/g) depending on the excipient used in the formulation (III). The 
preparation of granules is described above.  
 
4.3.2 Drying phase (I, III, V) 
Fluid bed drying (V) 
Fluid bed drying of wet theophylline granules was performed using a multichamber microscale 
fluid bed dryer (MMFD, Ariacon Oy, Turku, Finland) module with a process air control unit 
(Ilmasäätö Oy, Turku, Finland). The wet granules were sieved to fractions ranging from 1 to 2 mm 
and their batch size for fluid bed dryer was 10 ml. The temperature of the inlet air was varied from 
30 to 90 °C with steps of 10 °C. Moisture content of process air was less than 0.5 g /m3 of inlet air 
(i.e. dry inlet air) or 7.6 ± 0.3 g /m3 of inlet air (i.e. ambient inlet air). Drying time varied form 10 
min to 2 h depending on the drying temperature used (Fig. 4, in Paper V). Dried granules were 
divided in half and then one sample was measured by NIR and another one by XRPD. 
 
Variable temperature X-ray powder diffractometer (I, III, V) 
The tray drying process was simulated in the X-ray powder diffraction (XRPD) theta-theta 
diffractometer (Bruker axs D8, Bruker AXC GmbH, Karlsruhe, Germany) using variable 
temperatures. The wet granules of drying experiments (I, III, V) were placed into the holder 
(thickness of a sample ~1mm) of a variable temperature XRPD (VT-XRPD). The wet theophylline 
granules (V) were heated to 40, 50, 60 or 70 oC, and maintained at the target temperature for 15 h. 
The wet masses containing each excipient alone (I) or blend of nitrofurantoin anhydrate and 
excipients (1:1) (III) at the highest water contents of each formulation were heated with increments 
of 10 °C from 25 oC to 270 oC and maintained at the target temperature for 15 min. The variable 
temperature diffraction patterns of the wet masses were measured 24 h after water addition to 
ensure hydrate formation of nitrofurantoin. This method enabled following the phase 
transformations from nitrofurantoin monohydrate to anhydrate in excipient mixtures during the 
drying process.  
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4.4 Water sorption (I, III) 
4.4.1 Water sorption with the desiccator method (I, II, III) 
The moisture sorption properties of dried excipients (I) or 1:1 (w/w) mixtures with the anhydrous 
nitrofurantoin (III) were determined gravimetrically before and after storage at 22 °C under 
conditions of various relative humidities (0-95% RH) in the vacuum desiccator (Nalgene 
desiccator, Nalge Company, Rochester, NY, USA). The various RH conditions were achieved in 
vacuum desiccators using saturated salt solutions. Samples in triplicate in open glass vials were 
allowed to equilibrate in the vacuum desiccator and samples were weighed at room temperature 
after 2 weeks’ storage. Granules containing theophylline anhydrate and excipients (1:1) were dried 
on trays at 35 °C for 24 h (II). Water sorption properties of granules were determined 
gravimetrically before and after storage under 58, 75 and 85% RH conditions at 22 °C stored at 24, 
48, 120 and 163 h. The water sorption behaviour was evaluated from the average weight increase at 
each storage time and it was expressed as moisture increase (MI %) per starting weight. 
 
4.4.2 Water sorption isotherms by Dynamic Vapour Sorption method (I) 
The water sorption isotherms were measured using an accurate humidity- and temperature-
controlled microbalance system, Dynamic Vapour Sorption (DVS 1, Surface Management 
Systems, Ltd., 3 Warple Mews, Warple Way, London, UK). The RH was raised in steps from 0 to 
95% and back to 0% at 25 oC. The equilibration condition at each step of the RH for the rate of 
change in mass with time (dm/dt) was selected for each material separately. The mass changes were 
calculated with respect to the mass of the dried sample. The experimental monolayer water contents 
were determined from the sorption isotherms, using BET equations (Brunauer et al. 1938) and 
GAB equations (Anderson 1946, de Boer 1953, Guggenheim, 1966) for modelling the moisture 
sorption isotherms. 
 
 
4.5 Characterisation of solid dosage forms (I-V)  
Scanning electron micrographs (SEM) were used to document the changes in morphology of the 
dry mixture and granules of theophylline (II) after addition of the largest amount (0.2 g/g) of water. 
Scanning electron micrographs were documented by scanning electron microscopy (DSM962, 
Zeiss, Oberkochen, Germany). Moisture contents of theophylline granules (II, V) were determined 
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by loss on drying using an infrared (IR) dryer (Sartorius Thermocontrol YTC01L, Sartorius GmbH, 
Göttingen, Germany). Off-line evaluation of wet masses (II, III, IV), dry granules (V) and samples 
used in sorption studies (I, III) was performed using an X-ray powder diffractometer (XRPD) and 
near-infrared (NIR) spectroscopy.  
 
4.5.1 X-ray powder diffraction (I-V) 
X-ray diffraction patterns were measured using an X-ray powder diffraction (XRPD) theta-theta 
diffractometer (Bruker axs D8, Bruker AXC GmbH, Karlsruhe, Germany). The XRPD experiments 
were performed in symmetrical reflection mode with CuKα radiation (1.54 Å) using Göbel Mirror 
bent gradient multilayer optics. The scattered intensities were measured with a scintillation counter. 
The variable-temperature X-ray diffraction patterns were measured as previously described (I, III, 
V, Karjalainen et al. 2005). No replicate measurements were performed these samples. The 
accuracy of the XRPD quantification method is approximately ± 10%.  
 
4.5.2 Spectroscopic methods (I-V) 
Off-line near-infrared (NIR) spectra were measured with a Fourier Transform near-infrared (FT)-
NIR spectrometer (Bomem MD-160 DX, Hartmann & Braun, Quebec, Canada) (I-V). The spectra 
were measured through the bottom of a glass vial containing the sample. The measurements were 
carried out in triplicate. Second derivative transformations of absorbance, log (1/R), were 
performed with Savitzky-Golay smoothing (Savitzky and Golay 1964) using Matlab software (v. 
5.3, MathWorks Inc., Natick, MA, USA).  
 Raman spectra of the wet theophylline masses (II) were measured using a Raman 
spectrometer prototype (VTT-Electronics, Oulu, Finland). The measurements were performed in 
triplicate. Spectral intensities were normalised by standard normal variation (SNV) transformation 
(Barnes et al. 1989) using Matlab software (v. 5.3, MathWorks Inc., Natick, MA, USA).  
 
 36
RESULTS AND DISCUSSION 
_______________________________________________________________________________________ 
5. RESULTS AND DISCUSSION 
5.1 Water sorption behaviour of excipients (I) 
This study provides for comparison the following water sorption properties of 13 different 
excipients: water sorption isotherms, hygroscopicity, and changes in crystal structure after storage 
at various RH. This type of broad characterisation has not been made previously. 
 
5.1.1 Crystalline excipients  
The water adsorption and desorption isotherms of the crystalline excipients (MANN and LMH) 
approached the type III in behaviour in the IUPAC classification (Figs. 2A and 2B in paper I) when 
used DVS method. A type III isotherm shows very little moisture gain until water begins to dissolve 
the crystal surface. The shape of this curve is due to water interacting only via hydrogen bonds with 
the hydroxyl groups on the surface of the crystalline material (Bell and Labuza 2000). The 
adsorption-desorption isotherm of crystalline excipients showed no significant hysteresis. Our 
results showed that the water content of the crystalline LMH and MANN remained relatively 
constant at all RHs up to 95%, and MANN adsorbed like LMH very little moisture (Table 3) over 
the RH 0-85%. However, at above 85% RH MANN is adsorbed more moisture than LMH and the 
moisture content of MANN increases more than in the case of LMH (Figs. 2A and 2B, I). The 
reason for the significant increase in moisture content at high RH is capillary condensation and 
deliquescence. Many crystalline solids exhibit low hygroscopicity over a wide range, since the flow 
moisture point has been reached; the crystalline solid rapidly adsorbs large amounts of water vapour 
causing it to deliquesce. At high RH (more than 85%) the isotherm is therefore only valid for 
packed beds of lactose powders and capillary size distribution of the powder may influence the 
shape of the isotherm curve (Bronlund and Paterson 2004).  
 Non-hygroscopic crystalline excipients adsorb small amounts of water onto their external 
surface below a RH0 (Kontny and Zografi 1995). Condensed water, produced during deliquescence, 
continues to dissolve the excipient, but real dissolution of water-soluble crystalline substances does 
not occur below RH0. The RH0 for LMH is ~99% and for MANN is ~80% at 24-25°C (Hancock 
and Shamblin 1998), but when solubility increases, RH0 decreases (Kontny and Zografi 1995). It 
was also suggested that enhanced chemical and physical reactivity at the surface of crystals in the 
presence of water vapour may be due to plasticization of small disordered (amorphous) regions 
(Kontny et al. 1987). Non-hygroscopic crystalline excipients, LMH and MANN, showed minimal 
water adsorption properties and deliquescence at high RH. 
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 XRPD results showed that at 75% RH some additional features of the MANN diffraction 
patterns were also identified and the ratios of some intensity changed (Fig. 3A, I). Derbyshire et al. 
(2002) have reported that the hydration of MANN increased at water contents of about 0.1 g/g and 
0.25-0.3 g/g. The formation of a monolayer of water molecules would occur at hydration levels that 
are much lower than that of the observed transition. They suggested that these transitions were 
associated with different stages of micro-dissolution with increasing levels of hydration. Crystalline 
hydrates are frequently formed because they represent a lower thermodynamic energy state than the 
anhydrous form and water molecules may not be removed without the application of a large amount 
of energy (Hancock and Shamblin 1998). NIR results of MANN showed that some of the water is 
behaving like free water at 95% RH (Fig. 4A, I), which is consistent with previous findings 
(Derbyshire et al. 2002). At 95% RH, some additional features of the LMH diffraction patterns were 
identified, which closely reminded features of the diffraction patterns for anhydrous β-lactose (Fig. 
3A, I).  
 
Table 3. Changes in masses of excipients at 75-95% 
RH after moisture adsorption using DVS (I).  
 
Change in  mass (%)
Excipient 75%RH 85%RH 95%RH
LMH 0.038 0.068 0.222
MANN 0.083 0.152 0.542
MCC1 8.80 10.97 15.64
MCC2 8.96 11.13 15.77
MCC3 8.84 10.98 15.67
MCC4 8.90 11.02 15.61
SMCC1 8.80 11.10 16.50
SMCC2 8.54 10.75 16.16
LHPC1 17.00 21.60 35.62
LHPC2 16.89 21.42 35.23
LHPC3 16.86 21.50 35.61
PGSTA 16.45 19.73 28.87
STA 16.92* 20.04* 27.29*
*76.5 % RH *86% RH *96% RH
 
 
 
 
 
 
 
 
 
 
 
 
5.1.2 Amorphous part of excipients (I) 
Water sorption isotherms of celluloses (MCC, SMCC, LHPC) and starches (STA, PGSTA) were 
the sigmoidally shaped type II isotherm (Figs. 2C - 2F, I), which is in agreement with, for example, 
Al-Muhtaseb et al. (2004). With the results reported by Callahan et al. (1982), MCC and SMCC 
were slightly hygroscopic excipients. At low RH the isotherm curve showed a distinct knee, which 
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is often taken to indicate the stage at which monolayer coverage is complete and multilayer 
adsorption about to begin (Sing et al. 1985). Adorption-desorption equilibria of starches and 
celluloses always give rise to hysteresis (Zografi and Kontny 1986). Hysteresis, observed with 
MCC, SMCC and STA, indicates that water condenses into the pores by capillary condensation but 
only desorbs from them at lower RH than those required for condensation (Mangel 1999). SMCC1 
showed hysteresis (Fig. 2C, I), which increased continuously until 95% RH and both hysteresis and 
the hysteresis loop (type H4, IUPAC classification, after Sing et al. 1985) were different in starches 
(Figs. 2D and 2E, I) or LHPC2 (type H3, Fig. 2F, I). According to Sing et al. (1985) H4 hysteresis 
loops are often associated with narrow slit-shaped pores in the micropore range. A clearly evident 
characteristic is that the hysteresis remains over the entire RH range and, unlike in crystalline 
hydrates, water uptake occurs continuously. Partially amorphous materials, like MCC/SMCC and 
STA, tend to exhibit considerable bulk absorption of water, which is a slow diffusion-controlled 
process and thus part of the nonequilibrium regime (Kontny and Zografi 1995). 
 Very hygroscopic LHPC is insoluble in water but swells when it comes into contact with 
water. Hysteresis at low RH may be associated with swelling or with an irreversible chemical 
interaction between the adsorbate and the adsorbent (Sing et al. 1985, Mihranyan et al. 2004). The 
LHPC2 and starches absorbed more water than SMCC1 (Table 3), which is consistent with previous 
findings (Heidemann and Jarosz 1991, Kawashima et al. 1993,). Since the crystallinity of MCC is 
much higher than that of LHPC, there are few free hydroxyl groups in the MCC particles to undergo 
hydrogen bonding with the water molecule, compared with LHPC (Kawashima et al. 1993). The 
hysteresis of LHPC2 was reminiscent of that for STA (I). The hysteresis of LHPC2 was maximum 
at lower RH (30% RH) than that of STA (maximum at 60% RH). Type H3 hysteresis loops of 
LHPC2 exhibit no limiting sorption at high RH. Material that absorbs water into its internal 
structure exhibits sorption at lower RH in much greater amounts than is expected based on the 
specific surface area of the material, and exhibits hysteresis over the complete range of RH (Kontny 
and Zografi 1995). This type of hysteresis is generally explained by either kinetic effects or a 
change in the polymer-chain conformation caused by the plasticization effects of sorbed water 
(Zografi and Kontny 1986).  
 PGSTA showed a hysteresis gap remained over the entire RH range and the hysteresis loop of 
PGSTA was the largest of all the excipients (Fig. 2E, I). This may have been due to the differing 
structure of the excipients including starches; the extent of hysteresis may reflect the structural and 
conformational rearrangements, which alters the accessibility of energetically favourable polar sites 
and thus may hinder the movement of moisture (Al-Muhtaseb et al. 2004). The hysteresis of starch 
has been attributed to ink bottle pores in which the water cannot escape the pore (Newman et al. 
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1996). Although starch is able to take larger amounts of water into its internal structure, it was able 
to absorb less water than LHPC. Both starches were moderately hygroscopic materials, whereas 
LHPC was very hygroscopic (Fig. 2D-2F, I and Table 3). The NIR results of STA showed that free 
water had a gradually increasing absorption maximum at 95% RH, but less than with PGSTA (Fig. 
4C, I). According to Delwiche et al. (1991) the NIR spectra of starch suggest that some multilayer 
water is present before the monolayer is completed. The NIR results of LHPC2 showed that free 
water had a gradually increasing absorption maximum at 95% RH, but not at 75% RH (Fig. 4B, I). 
The same phenomenon, but not as high as in LHPC2, was observed with SMCC1 and PGSTA.  
 The crystallinity of starches increased as a result of increased RH, but at 95% RH the final 
crystallinity of STA (55%) was higher than that of PGSTA (30%) (Figs. 2D, 2E and 3C, I). All 
amorphous sugars have a strong tendency to take up water vapour. At high RH sorption of water by 
an amorphous sugar may cause crystallization of that sugar, and this process can have significant 
consequences for the stability of pharmaceutical formulations (Ahlneck and Zografi 1990). 
Crystallization is usually the limiting factor determining how much water vapour can be taken-up 
by amorphous low-molecular-weight sugars (Hancock and Shamblin 1998). Our results showed that 
the more amorphous excipient the more water was absorbed into the structure of excipient. The 
most hygroscopic (Table 3) and stable excipient was amorphous LHPC; it showed no significant 
hysteresis and no changes in structure.  
 
 
5.2 Effects of excipients on the physical stability in the solid formulations 
5.2.1 Role of excipients in wet granulation (II, III, IV) 
Crystalline model APIs, theophylline (II, IV) or nitrofurantoin anhydrates (III), without any 
excipients transformed completely to monohydrate with the first addition of water on the first day 
(I, IV) as expected. But excipients can significantly affect solid-state phase transitions in the 
formulation. Crystalline excipient in the formulation was unable to control hydrate formation of 
API. Addition of crystalline LMH to the formulation enhanced or slightly increased the hydrate 
formation rate of API in comparison with a formulation containing only anhydrous API. Our results 
were consistent with results reported earlier by Otsuka and Matsuda (1994); the hydration of 
nitrofurantoin containing LMH in the formulation was faster and it occurred at lower water content 
than formulation containing SMCC.  
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 Relatively low percentages of amorphous material can absorb considerable amounts of water 
into their structure (Kontny and Zografi 1995). The slightly hygroscopic and partially crystalline 
excipient SMCC in the formulation hindered hydrate formation of API at low water contents. 
SMCC decreased the hydrate formation rate by absorbing water at low moisture contents, but did 
not inhibit it at the amounts of water needed to form granules. SMCC (or MCC) absorbed less water 
than LHPC, which is consistent with previous findings (Kawashima et al. 1993). The smallest pores 
of the MCC/SMCC fill first with water due to capillary condensation. So the absorption rate 
becomes slower after the initial sorption of water into the micropores. We suppose that capillary 
condensation may transfer water into the crystal lattice of anhydrous API quicker than it can be 
absorbed into the remaining macropores of amorphous SMCC. The surface interaction of water 
directly with theophylline anhydrate at water contents above the monolayer moisture content may 
also be involved. 
 The less crystalline excipient used in the formulation, the more water is absorbed into 
structure of excipient. Formulations containing PGSTA or LHPC were absorbed water more slowly 
than formulations containing SMCC, and the physical stability of API increased. Moderately 
hygroscopic PGSTA was able to hinder the formation of nitrofurantoin monohydrate at higher (1.5 
g/g, ~60% w/w) water contents than SMCC, but at lower water contents than LHPC. LHPC 
inhibited hydrate formation of nitrofurantoin at high water contents, even at content of 4 g/g (~80% 
w/w) of water. Determination by NIR showed that after addition of 3 g/g (~75% w/w) water to 
LHPC formulation or of 1 g/g (~50% w/w) water to PGSTA formulation, the added water was seen 
only as free water because the saturation point of NIR had been reached. In summary, amorphous 
LHPC inhibited hydrate formation of API even at high water contents during wet granulation. 
 
5.2.2 Role of excipients in hydrate formation kinetics (IV) 
In this study the hydrate formation kinetics in wet granulation processes were elucidated for the first 
time. The effect of excipients on hydrate formation kinetics of theophylline during wet granulation 
was studied using NIR spectroscopy. Anhydrous theophylline was chosen as the hydrate-forming 
model API and two excipients, SMCC and LMH, were used in the formulation. The dissolution rate 
from the anhydrous phase and the growth rate of the hydrate phase are involved in the kinetics of 
the anhydrous to hydrate transition of theophylline. This is due to the solution-mediated route of 
hydrate formation (Rodriguez-Hornedo et al. 1992). LMH slightly increased the hydrate formation 
rate in comparison with a mass comprising only anhydrous theophylline (Fig. 1A and 1B, IV). The 
amount of theophylline monohydrate was greater at the beginning in the theophylline-LMH wet 
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mass than in the theophylline mass alone (Fig. 3A and 3B, IV). There was no significant difference 
in the measured intrinsic dissolution rates of theophylline in water and lactose solution, thus this 
can not explain the observed difference in the hydrate formation kinetics. But the presence of 
dissolved LMH among the theophylline particles could have facilitated the distribution of water and 
the wetting of the theophylline particles. LMH could have enhanced the hydrate formation by 
providing the water faster on the theophylline particle surfaces. The hydrate formation of 
theophylline was slower in the presence of SMCC in the formulation (Fig. 1C and 3C, IV). The 
presence of SMCC could have affected the dissolution rate of anhydrous theophylline by absorbing 
a part of the added water in its structure and thereby slowing down the hydrate formation rate. The 
results indicate that NIR spectroscopy can be applied to follow the migration of water in the wet 
masses, which can affect e.g. formation of hydrates of API.  
 
5.3 Thermal behaviour of formulations 
5.3.1 Evaluation of thermal processing induced phase transformation (I, III) 
Formulations containing crystalline excipients (LMH, MANN) showed differences in their crystal 
structures and dehydration behaviour (Fig. 5A and 5B, I). LMH dehydrates at ca. 150 °C loosing 
the water of crystallization and some features of the diffraction patterns for anhydrous β-lactose 
could also be identified during the thermal process at 150-170 °C, in accord with previous reports 
(Garnier et al. 2002). The wet mass of LMH was transformed and irreversibly attained anhydrous 
crystalline structure at 180 °C, as expected. Formulations containing nitrofurantoin monohydrate 
(III) and crystalline LMH showed rapid dehydration behaviour starting already at 110-120 °C (Fig. 
6, III), whereas dehydration of pure nitrofurantoin monohydrate started later (120-130 °C) as 
reported earlier (127 °C) by Caira et al. (1996). The bigger particle size of crystallized 
nitrofurantoin monohydrate compared with excipient-nitrofurantoin monohydrate blends could 
affect the dehydration rate of water. Water molecules are contained in isolated cavities in 
nitrofurantoin monohydrate, resulting in a higher temperature of dehydration (Caira et al. 1996). 
 Diffraction pattern of MANN (I) showed transformation from crystalline form of MANN to 
amorphous form at 160 °C (Fig. 5B, I), because at this temperature is melting point of MANN 
(Kibbe 2000). After drying and then cooling back to room temperature the polymorphic β form of 
MANN transformed to the new form, which remained in the polymorphic α form identified 
previously (Berman et al. 1968, Burger et al. 2000, Yoshinari et al. 2002). Crystalline excipients are 
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stable only at relatively low temperatures used in the drying phase of wet granulation compared 
with those used in the thermal processes. 
 If starch granules are heated in the presence of at least 60% water and their Tg is reached, the 
plasticized amorphous regions of the granule undergo a phase transition from a glass to a rubber 
(Whistler and BeMiller 1997). In our study, starches were heated in the presence of 1.5g/g (~60% 
w/w) of water. The partially amorphous STA transformed to amorphous form and amorphous 
PGSTA remained mainly amorphous at 260 °C even after cooling (Figs. 5D and 5E, I). However, it 
appeared that some amylose of both starches recrystallized after heating and cooling in a VT-
XRPD, despite that the crystallinity of the starches remained low. When the starting formulation 
contained amorphous PGSTA and nitrofurantoin monohydrate, gelatinized PGSTA formulation 
probably dried from the surface of wet mass during heating and hindered moisture movement 
before the nitrofurantoin anhydrate transformed totally. Thus, the relative amount of nitrofurantoin 
monohydrate remained high in the formulation until the end of drying (Fig. 6, III). Water affects the 
structure of starches acting as a plasticizer of the amorphous regions and thus decreasing 
gelatinization temperature of starches (Roos 1995). The gelatinization of starch granules occurs 
over a temperature range of 60-100 °C depending on moisture content (Fukuoka et al. 2002). 
According to the Aguerre and Suarez (2004), the properties of the diffusion of moisture in starch 
grains are directly related to moisture desorption isotherm. The hysteresis loop of sorption 
isotherms of PGSTA was the largest of all the excipients and a hysteresis gap remained over the 
entire RH range (Fig. 2E, I). This means that the absorbed water remained in the structure of starch 
or moisture delivered slower by diffusion mechanism, and the delayed movement of water was due 
to structural changes caused by gelatinization. 
 Celluloses (SMCC and LHPC) gave the most stable formulations, when evaluated thermal 
processing behaviour of wet masses by VT-XRPD (Figs. 5C and 5F, I). They did not change 
permanently, in contrast to starches (STA and PGSTA). The thermal processing of celluloses with 
model API nitrofurantoin monohydrate after heating up to 200 °C showed no differences in their 
structure. The moisture was absorbed into the amorphous structure of LHPC gradually in the 
formulations with nitrofurantoin monohydrate; that means LHPC equilibrated slowly (Fig. 4D, III). 
Therefore amorphous excipients often could deliver moisture slower than the crystalline excipients 
using diffusion as a dehydration process. However, in the wet nitrofurantoin–LHPC formulation, 
the nitrofurantoin monohydrate transformed totally to anhydrous form already at 150 °C (Fig. 6, 
III), which was different from formulation with amorphous PGSTA. This result was consistent with 
the results of sorption studies (I): the moisture absorption isotherm of LHPC (Fig. 2F, I) reminded 
that of PGSTA (Fig. 2E, I), but the hysteresis loop of LHPC was smaller than loop of PGSTA 
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meaning that LHPC desorbed moisture quicker than PGSTA and retained unchanged structure. 
Thus, in this study LHPC in the formulation seemed to protect the API most during drying. Wet 
formulations of LHPC equilibrated more slowly than SMCC, but LHPC did not retard dehydration 
behaviour of nitrofurantoin, like SMCC or PGSTA, during heating process (Fig. 6, III).   
 
5.3.2 Comparison of different drying methods (V) 
Metastable anhydrous theophylline was the major form that was produced at drying temperatures of 
40-50 oC with both fluid bed dryer (MMFD) and VT-XRPD drying techniques (Figs. 2A, 2B, 3A 
and 3B, V). Morris et al. (2001) suggested that fluid bed drying at low temperature favours 
metastable form of theophylline anhydrate. Our results showed that of the three forms of 
theophylline, metastable anhydrous theophylline was the major form between 40 oC and 50 oC with 
both drying techniques. Drying at temperatures over 50 oC produced mostly stable anhydrous 
theophylline, which is consistent with previous findings by Morris et al. (2001). Although drying at 
temperatures over 50 oC produced mostly stable anhydrous theophylline, over 20% metastable 
anhydrous theophylline remained even at 90 oC when drying in an MMFD (drying time 10 min, the 
moisture contents of dried granules varied from 0.5-0.7%, Figs. 2A and 2B, V). In contrast, drying 
the granules in a VT-XRPD produced only stable anhydrous theophylline after the first 15 min at  
60 oC (Fig. 3C, V). 
 Theophylline granules should be relatively easy to dry due to the extensive distribution of 
water within the capillaries and the large water tunnels. Whenever a wet suspension containing a 
drug substance is dried, the possibility exists that a change in its crystal state will take place. The 
drying process may not completely remove all the moisture. After wet granulation, granules usually 
have some moisture left; it is practical to maintain a residual amount of moisture in the granulation, 
e.g. to avoid excess granule attrition during drying phase and to allow successful tabletting process. 
The level of residual moisture of the granulation process is one of the main factors in ensuring 
adequate compression (Terrier de la Chaise and LePerdriel 1972). The combination of solvent and 
drying conditions provides a suitable environment for the generation of new polymorphs (Brittain 
and Fiese 1999). The dehydration threshold temperature is the temperature at which 2% of the 
solvent (here water) is lost and this dehydration threshold temperature for theophylline hydrate is 
47.3 °C (Perrier and Byrn 1982). The threshold temperature of drying is related to the tunnel area, 
crystal packing, and perhaps also to defects within the crystal and the hydrogen-bond energy, which 
in turn is related to the length of the hydrogen bonds (Byrn et al. 1999). Theophylline monohydrate 
is a slow-reacting hydrate with short and strong hydrogen bonds. This could explain why drying at 
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temperatures 40-50 oC produced mostly metastable anhydrous theophylline especially during the 
fast drying process in the MMFD. To reduce the metastable form from dried theophylline granules, 
it seems that drying temperatures for theophylline monohydrate should be much higher than the 
dehydration threshold temperature of theophylline monohydrate.  
 When drying is done in an MMFD, the granules are in suspended hot air and the heat transfer 
is extremely rapid. Fluid bed granules usually have large porosity, which helps water to exit easily. 
Because the water tunnels of theophylline monohydrate are relatively large (Byrn et al. 1999), free 
water can escape easily at the beginning of dehydration. But since the shape of water tunnels is 
zigzag (Perrier and Byrn 1982), the rest of water remains in the tunnel, and total drying 
consequently takes a longer time. Drying in an MMFD was done after the drying phase of normal 
fluid bed granulation and was stopped when the humidity of the inlet and outlet air were the same. 
The drying time of the granules varied depending on the drying temperature in the MMFD. As 
expected, higher drying temperatures led to shorter drying times. 
 In tray drying, the bed thickness, i.e. the mass of the granules, has a critical influence on 
drying (Carstensen and Zoglio 1982). During drying in a VT-XRPD (simulated tray drying), the 
bed is fixed and the drying process is slower than when a MMFD is used, whereas during drying in 
a fluid bed, triboelectrification of powders may cause cohesion effects, the initial formation of 
agglomerates and adhesion to the wall of the container. Since in an MMFD the material is under 
higher mechanical attrition than in VT-XRPD during the drying process, we proposed that 
differences in attrition that produce recrystallization may explain the differences in metastable form 
generation between VT-XRPD and the fluid bed dryers. Moreover increased triboelectrification of 
the granules during MMFD drying might produce preferred orientation to the crystals. These effects 
are emphasized in microscale fluid bed drying, in which the amount of dried material is small and a 
larger proportion of the granules are in contact with the container wall than in a traditional fluid bed 
unit.  
 These results indicated that using additional drying methods, including an MMFD, during the 
preformulation phase may be more informative about possible polymorphic transformations in the 
drug ingredients during the manufacturing process. This study showed that drying in a fluid bed 
dryer produces greater relative amount of the metastable form of theophylline than drying in a VT-
XRPD (simulated tray drying) under apparently similar temperature conditions and regardless of the 
humidity of the inlet air. Although the exact mechanism causing the difference in metastable form 
generation between the two drying methods remains unclear, our findings raised the question 
whether fluid bed drying may produce higher amounts of an unstable polymorphic form than other 
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drying methods, such as oven-drying. Another open question is the effect of triboelectrification on 
polymorphism during the fluid bed processes. Additional research is needed to determine the role of 
excipients in the formation of metastable forms during fluid bed drying. In practice, excipients are 
always present in the formulation during the drying phase both in fluid bed granulation and other 
drying processes. Since the excipients can have significant effects on the structure of theophylline 
(II), it is possible that their presence may inhibit the formation of metastable forms in formulation 
during fluid bed drying. 
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6. CONCLUSIONS 
The following conclusions are drawn from this study: 
1. This study provides the moisture sorption properties (like sorption isotherms, hygroscopicity, 
and changes in crystal structure after storage at various RH) of 13 different excipients with 
different degree of crystallinity in one report. This can facilitate excipient comparison 
regarding to preformulation stage, and thus helps to predict the solid-state stability and 
interactions of the final formulations.  
2. The degree of crystallinity of excipients had a significant effect on the stability of 
formulation. In general, the more amorphous the excipient, the more water was absorbed 
into its structure. The most hygroscopic and stable excipient in this study was amorphous 
LHPC, which showed no significant hysteresis and no changes in structure even at the 
highest RH. Non-hygroscopic crystalline excipients, LMH and MANN, showed minimal 
water adsorption properties and deliquescence phenomenon at high RH.  
3. The crystallinity of excipients was correlated with the ability of the excipients to inhibit 
hydrate formation of two model APIs (nitrofurantoin and theophylline). Of four excipients 
tested, the amorphous and very hygroscopic LHPC was able to inhibit hydrate formation of 
nitrofurantoin at relatively high water contents during wet granulation. Partially crystalline 
and the slightly hygroscopic excipient SMCC and the moderately hygroscopic starch 
retarded the hydrate formation of the APIs at lower water contents, whereas the non-
hygroscopic crystalline excipient LMH could not reduce hydrate formation.  
4. This study is the first to elucidate hydrate formation kinetics in wet granulation processes. It 
shows that SMCC slowed down the rate of theophylline hydrate formation, but could not 
inhibit it. SMCC may affect the dissolution rate of anhydrous theophylline by absorbing a 
part of the added water into its internal structure and thereby slowing down the hydrate 
formation rate. LMH could enhance the hydrate formation of theophylline possibly by 
providing the water faster on the particle surfaces of theophylline. 
5. At low water contents, a spectroscopic approach enables phase transformations in the 
formulation to be identified even though there were excipients in the formulation. At high 
water contents the saturation point of NIR had been reached and different states of water 
were not possible to distinguish. 
6. Process temperature and excipients in the formulation had a significant influence on phase 
transitions in drying process. Metastable theophylline was the predominant form produced 
after drying at 40 - 50 oC using MMFD or VT-XRPD. MMFD drying, however, generated 
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more metastable form of anhydrous theophylline than VT-XRPD at temperatures over 50 
oC, possibly due to differences in attrition and increased triboelectrification of the granules. 
These results indicate that using additional drying methods, including an MMFD, during the 
preformulation phase may be more informative about possible polymorphic transformations 
in the drug ingredients during the manufacturing process.  
 During thermal drying of wet formulations with VT-XRPD, SMCC and especially 
LHPC were the most stable excipients. Therefore, LHPC did not retard dehydration of 
nitrofurantoin during the heating of wet formulation. In contrast, MANN transformed to 
another polymorphic form after cooling and starches recrystallized during the heating 
processes. The formulation with starch contained nitrofurantoin monohydrate still in the end 
of the heating, probably because gelatinised starch had hindered moisture movement. 
 
To conclude, as changes in the crystal forms can affect performance or stability of the solid 
dosage form, they should be known and controlled. Since interaction of moisture with 
pharmaceutical solids can result in unexpected PITs, correct selection of excipients helps to 
control PITs and can improve the manufacturing and the storage stability of the final 
formulations. 
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